{"content":"<li class=\"n-box-item date-title\" data-end=\"1573621199\" data-start=\"1573534800\" data-txt=\"Monday, December 23, 2019\">Tuesday, November 12, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3518459\" data-ts=\"1573603137\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YY\" target=\"_blank\">YY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518459-yyplus-4_3-q3-beats-on-top-bottom-lines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">YY +4.3% as Q3 beats on top, bottom lines</a></h4><ul>   <li><a href='https://seekingalpha.com/symbol/YY' title='YY Inc.'>YY</a> is <font color=\"green\">up 4.3%</font> after hours following its easy clearing of analysts' bar in its <a href=\"https://seekingalpha.com/news/3518447-yy-eps-beats-0_09-beats-revenue\" target=\"_blank\">Q3 report</a>.</li>    <li>Net revenues rose by 67.8% to 6.882B yuan (about $962.9M).</li>    <li>Amid slightly faster-growing cost of revenues, gross profit rose by 52.1% to 2.17B yuan (about $303.5M). Gross margin dipped to 31.5% from a previous 34.8%.</li>    <li>Operating income fell to 160.3M yuan from 610.9M yuan amid sharply higher operating expenses. Non-GAAP operating income dipped to 611.4M yuan from 774.2M yuan.</li>    <li>And attributable non-GAAP net income fell to 574.1M yuan from 787M yuan.</li>    <li>For Q4, it's guiding to net revenues of 7.32B-7.52B yuan, or year-over-year growth of 57.7%-62.2%.</li>    <li><a href=\"https://edge.media-server.com/mmc/p/4v7xqjqp\" target=\"_blank\">Conference call</a> to come at 9 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/17696957-yy-reports-third-quarter-2019-unaudited-financial-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3518459\" data-linked=\"YY +4.3% as Q3 beats on top, bottom lines\" data-tweet=\"$YY - YY +4.3% as Q3 beats on top, bottom lines https://seekingalpha.com/news/3518459-yyplus-4_3-q3-beats-on-top-bottom-lines?source=tweet\" data-url=\"https://seekingalpha.com/news/3518459-yyplus-4_3-q3-beats-on-top-bottom-lines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518456\" data-ts=\"1573602211\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HUYA\" target=\"_blank\">HUYA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518456-huyaplus-3_1-on-q3-beat-heavy-revenue-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Huya +3.1% on Q3 beat, heavy revenue growth</a></h4><ul>   <li>Game streaming platform Huya (NYSE:<a href='https://seekingalpha.com/symbol/HUYA' title='HUYA Inc.'>HUYA</a>) is <font color=\"green\">up 3.1%</font> postmarket after topping consensus expectations with its <a href=\"https://seekingalpha.com/news/3518445-huya-broadcasting-eps-beats-0_01-beats-revenue\" target=\"_blank\">Q3 earnings report</a>.</li>    <li>Net revenues rose by 77.4% to 2.265B yuan (about $316.9M) as gains in advertising added to the company's core streaming revenues.</li>    <li>And gross profit more than doubled, to 406.3M yuan (about $56.8M). Gross margin rose to 17.9% from 15.2%.</li>    <li>The company swung to an operating gain of 63.9M yuan from a year-ago loss of 2.7M yuan; non-GAAP operating income rose to 147M yuan from 61.5M yuan.</li>    <li>Net income rose 70.5% to 206.4M yuan (about $28.9M).</li>    <li>Revenue breakout: Live streaming, 2.16B yuan (up 77.2%); Advertising and other, 109M yuan (up 81.3%).</li>    <li>In operations, average mobile monthly active users rose 29.1% to 63.8M. Average MAUs overall rose 47.6% to 146.1M, and total paying users grew 28.5% to 5.3M.</li>    <li>For Q4, it's guiding to net revenue of 2.34B-2.42B yuan or year-over-year growth of 55.5%-60.8%.</li>    <li><a href=\"http://ir.huya.com/\" target=\"_blank\">Conference call</a> to come at 8 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/17696956-huya-inc-reports-third-quarter-2019-unaudited-financial-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3518456\" data-linked=\"Huya +3.1% on Q3 beat, heavy revenue growth\" data-tweet=\"$HUYA - Huya +3.1% on Q3 beat, heavy revenue growth https://seekingalpha.com/news/3518456-huyaplus-3_1-on-q3-beat-heavy-revenue-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3518456-huyaplus-3_1-on-q3-beat-heavy-revenue-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518454\" data-ts=\"1573600677\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYBR\" target=\"_blank\">CYBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518454-cyberarkminus-2_8-on-500m-convertible-debt-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CyberArk -2.8% on $500M convertible debt offering</a></h4><ul>   <li>CyberArk Software (NASDAQ:<a href='https://seekingalpha.com/symbol/CYBR' title='CyberArk Software Ltd.'>CYBR</a>) is <font color=\"red\">2.8% lower</font> postmarket after proposing a private offering of <a href=\"https://seekingalpha.com/pr/17696672-cyberark-software-ltd-announces-proposed-private-offering-500-million-convertible-senior\" target=\"_blank\">$500M in senior debt</a>.</li>    <li>The company intends to offer that amount in convertible senior notes due 2024.</li>    <li>Initial purchasers should get a 13-day option to buy up to an additional $75M worth.</li>    <li>It will also enter into capped call transactions to reduce potential dilution on any conversion.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3518454\" data-linked=\"CyberArk -2.8% on $500M convertible debt offering\" data-tweet=\"$CYBR - CyberArk -2.8% on $500M convertible debt offering https://seekingalpha.com/news/3518454-cyberarkminus-2_8-on-500m-convertible-debt-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3518454-cyberarkminus-2_8-on-500m-convertible-debt-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518446\" data-ts=\"1573599765\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KNSL\" target=\"_blank\">KNSL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518446-kinsale-capitalplus-6_2-on-addition-to-smallcap-600\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kinsale Capital +6.2% on addition to SmallCap 600</a></h4><ul>   <li>Kinsale Capital Group (NASDAQ:<a href='https://seekingalpha.com/symbol/KNSL' title='Kinsale Capital Group, Inc.'>KNSL</a>) is <font color=\"green\">up 6.2%</font> postmarket after news that it's <a href=\"https://us.spindices.com/documents/indexnews/announcements/20191112-1031765/1031765_6kinsalefoods.pdf?force_download=true\" target=\"_blank\">joining the S&amp;P SmallCap 600 index</a>.</li>    <li>It's replacing Dean Foods, which has <a href=\"https://seekingalpha.com/news/3517879-dean-foods-files-chapter-11\" target=\"_blank\">filed for voluntary bankruptcy</a> and isn't eligible for inclusion anymore.</li>    <li>The move is effective prior to the open of trading on Monday, Nov. 18.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3518446\" data-linked=\"Kinsale Capital +6.2% on addition to SmallCap 600\" data-tweet=\"$KNSL - Kinsale Capital +6.2% on addition to SmallCap 600 https://seekingalpha.com/news/3518446-kinsale-capitalplus-6_2-on-addition-to-smallcap-600?source=tweet\" data-url=\"https://seekingalpha.com/news/3518446-kinsale-capitalplus-6_2-on-addition-to-smallcap-600\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518443\" data-ts=\"1573599336\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RIOT\" target=\"_blank\">RIOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518443-riot-blockchain-eps-beats-0_03-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Riot Blockchain EPS beats by $0.03, misses on revenue</a></h4><ul><li>Riot Blockchain (NASDAQ:<a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>): Q3 GAAP EPS of -$0.08 <font color=\"green\">beats by $0.03</font>.</li><li>Revenue of $1.7M (-26.1% Y/Y) <font color=\"red\">misses by $1.1M</font>.</li><li>Shares <font color=\"green\">+1.5%</font> AH.</li><li><a href=\"https://seekingalpha.com/pr/17696948-riot-blockchain-announces-september-30-2019-quarterly-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3518443\" data-linked=\"Riot Blockchain EPS beats by $0.03, misses on revenue\" data-tweet=\"$RIOT - Riot Blockchain EPS beats by $0.03, misses on revenue https://seekingalpha.com/news/3518443-riot-blockchain-eps-beats-0_03-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3518443-riot-blockchain-eps-beats-0_03-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518439\" data-ts=\"1573598654\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SWAV\" target=\"_blank\">SWAV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518439-shockwave-medicalminus-4_8-amid-75m-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shockwave Medical -4.8% amid $75M equity offering</a></h4><ul>   <li>Shockwave Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/SWAV' title='ShockWave Medical, Inc.'>SWAV</a>) is <font color=\"red\">4.8% lower</font> postmarket after <a href=\"https://seekingalpha.com/filing/4695963\" target=\"_blank\">filing to offer $75M worth</a> of common stock.</li>    <li>That comes to just over 2.075M shares as of yesterday's closing price.</li>    <li>The offering comes via Morgan Stanley and BofA Securities.</li>    <li>Net proceeds are estimated at $70M, or $80.6M if underwriters fully exercise their greenshoe option. They're earmarked along with existing liquidity to support commercialization of the IVL System, for R&amp;D and clinical studies and for working capital.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3518439\" data-linked=\"Shockwave Medical -4.8% amid $75M equity offering\" data-tweet=\"$SWAV - Shockwave Medical -4.8% amid $75M equity offering https://seekingalpha.com/news/3518439-shockwave-medicalminus-4_8-amid-75m-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3518439-shockwave-medicalminus-4_8-amid-75m-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518432\" data-ts=\"1573598096\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518432-csiq-halo-twou-and-ddog-among-after-hour-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CSIQ, HALO, TWOU and DDOG among after hour movers</a></h4><ul><li><strong>Gainers: </strong><a href='https://seekingalpha.com/symbol/CDLX' title='Cardlytics, Inc.'>CDLX</a> <font color=\"green\">+20.8%</font>. <a href='https://seekingalpha.com/symbol/TWOU' title='2U, Inc.'>TWOU</a> <font color=\"green\">+14.6%</font>. <a href='https://seekingalpha.com/symbol/DDOG' title='Datadog, Inc.'>DDOG</a> <font color=\"green\">+14.2%</font>. <a href='https://seekingalpha.com/symbol/VRAY' title='ViewRay, Inc.'>VRAY</a> <font color=\"green\">+9.3%</font>. <a href='https://seekingalpha.com/symbol/NBRV' title='Nabriva Therapeutics plc'>NBRV</a> <font color=\"green\">+8.4%</font>.</li><li><strong>Losers: </strong><a href='https://seekingalpha.com/symbol/CSIQ' title='Canadian Solar Inc.'>CSIQ</a> <font color=\"red\">-9.8%</font>. <a href='https://seekingalpha.com/symbol/NXTC' title='NextCure, Inc.'>NXTC</a> <font color=\"red\">-7.8%. </font><a href='https://seekingalpha.com/symbol/MRKR' title='Marker Therapeutics, Inc.'>MRKR</a> <font color=\"red\">-6.9%</font>. <a href='https://seekingalpha.com/symbol/SDC' title='SmileDirectClub, Inc.'>SDC</a> <font color=\"red\">-5.5%</font>. <a href='https://seekingalpha.com/symbol/HALO' title='Halozyme Therapeutics, Inc.'>HALO</a> <font color=\"red\">-4.6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3518432\" data-linked=\"CSIQ, HALO, TWOU and DDOG among after hour movers\" data-tweet=\"$CDLX $TWOU $DDOG - CSIQ, HALO, TWOU and DDOG among after hour movers https://seekingalpha.com/news/3518432-csiq-halo-twou-and-ddog-among-after-hour-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3518432-csiq-halo-twou-and-ddog-among-after-hour-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518430\" data-ts=\"1573597962\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NXTC\" target=\"_blank\">NXTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518430-nextcureminus-7_8-after-filing-to-offer-3_2m-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NextCure -7.8% after filing to offer 3.2M shares</a></h4><ul>   <li>NextCure (NASDAQ:<a href='https://seekingalpha.com/symbol/NXTC' title='NextCure, Inc.'>NXTC</a>) is <font color=\"red\">7.8% lower</font> after hours after <a href=\"https://seekingalpha.com/filing/4695940\" target=\"_blank\">filing to offer 3.2M shares</a> of common stock.</li>    <li>The offering comes through Morgan Stanley, BofA and Piper Jaffray along with Needham and BTIG.</li>    <li>Net proceeds are estimated at $116.5M, or $134.1M if underwriters fully exercise their option; those proceeds along with existing liquidity will be used primarily to advance NC318 through completion of a Phase 1/2 clinical trial, a planned Phase 2 clinical trial, and additional Phase 2 and 3 trials as well.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3518430\" data-linked=\"NextCure -7.8% after filing to offer 3.2M shares\" data-tweet=\"$NXTC - NextCure -7.8% after filing to offer 3.2M shares https://seekingalpha.com/news/3518430-nextcureminus-7_8-after-filing-to-offer-3_2m-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3518430-nextcureminus-7_8-after-filing-to-offer-3_2m-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518399\" data-ts=\"1573596119\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HALO\" target=\"_blank\">HALO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518399-halozyme-readies-convertible-debt-offering-shares-down-8-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Halozyme readies convertible debt offering; shares down 8% after hours</a></h4><ul><li>Halozyme (NASDAQ:<a href='https://seekingalpha.com/symbol/HALO' title='Halozyme Therapeutics, Inc.'>HALO</a>) <a href=\"https://seekingalpha.com/pr/17696723-halozyme-therapeutics-inc-announces-proposed-offering-400-million-convertible-senior-notes\" target=\"_blank\">initiates </a>a $400M offering of convertible senior notes due 2024. Price, volume and terms have yet to be announced.</li><li>Shares are under pressure after its <a href=\"https://seekingalpha.com/news/3518245-halozyme-q3-top-line-80-percent-guidance-cut\" target=\"_blank\">Q3 miss and guidance cut</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3518399\" data-linked=\"Halozyme readies convertible debt offering; shares down 8% after hours\" data-tweet=\"$HALO - Halozyme readies convertible debt offering; shares down 8% after hours https://seekingalpha.com/news/3518399-halozyme-readies-convertible-debt-offering-shares-down-8-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3518399-halozyme-readies-convertible-debt-offering-shares-down-8-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518398\" data-ts=\"1573596095\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RUN\" target=\"_blank\">RUN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518398-sunrun-rises-after-q3-earnings-topper\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sunrun rises after Q3 earnings topper</a></h4><ul><li>Sunrun (NASDAQ:<a href='https://seekingalpha.com/symbol/RUN' title='Sunrun Inc.'>RUN</a>) <font color=\"green\">+2.5%</font> after-hours following better than expected <a href=\"https://seekingalpha.com/news/3518243-sunrun-eps-beats-0_19-beats-revenue\" target=\"_blank\">Q3 earnings</a> and revenues, and the company's board authorizes a $50M stock buyback program.</li><li>RUN says megawatts deployed during Q3 rose 7% Y/Y to 107 MW from 100 MW in the prior-year quarter but at the low end of 107-110 MW guidance; creation cost per watt was $3.28 in Q3 vs. $3.34 in the year-ago quarter.</li><li>RUN says it expects Q4 deployments in a range of 115-118 MW.</li><li>The company says it \"has grown its customer base 24% from last year, with more than 270K homes embracing local, clean energy. We expect to increase cash generation by 60% to $100M this year.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3518398\" data-linked=\"Sunrun rises after Q3 earnings topper\" data-tweet=\"$RUN - Sunrun rises after Q3 earnings topper https://seekingalpha.com/news/3518398-sunrun-rises-after-q3-earnings-topper?source=tweet\" data-url=\"https://seekingalpha.com/news/3518398-sunrun-rises-after-q3-earnings-topper\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518395\" data-ts=\"1573596026\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CDAY\" target=\"_blank\">CDAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518395-thomas-h-lee-cannae-to-sell-10m-ceridian-hcm-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Thomas H. Lee, Cannae to sell 10M Ceridian HCM shares</a></h4><ul><li>Ceridian HCM Holding (NYSE:<a href='https://seekingalpha.com/symbol/CDAY' title='Ceridian HCM Holding Inc.'>CDAY</a>) falls <font color=\"red\">1.9%</font> in after-hours trading after existing shareholders Thomas H. Lee Partners and Cannae Holdings (NYSE:<a href='https://seekingalpha.com/symbol/CNNE' title='Cannae Holdings, Inc.'>CNNE</a>) each<a href=\"https://seekingalpha.com/pr/17696807-ceridian-launches-secondary-public-offering\" target=\"_blank\"> plan to offer </a>5M CDAY shares in secondary public offering.</li><li>In September, Thomas H. Lee Partners sold 6.5M CDAY shares and Cannae sold 2M shares. After that offering, Thomas H. Lee was expected to hold 23.7M shares and Cannae was expected to hold 28.7M shares.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3497202-ceridian-announces-pricing-secondary-public-offering\" target=\"_blank\">Ceridian announces pricing of secondary public offering</a> (Sept. 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3518395\" data-linked=\"Thomas H. Lee, Cannae to sell 10M Ceridian HCM shares\" data-tweet=\"$CDAY $CNNE - Thomas H. Lee, Cannae to sell 10M Ceridian HCM shares https://seekingalpha.com/news/3518395-thomas-h-lee-cannae-to-sell-10m-ceridian-hcm-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3518395-thomas-h-lee-cannae-to-sell-10m-ceridian-hcm-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518392\" data-ts=\"1573595917\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BCRX\" target=\"_blank\">BCRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518392-biocryst-down-8-after-hours-on-planned-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioCryst down 8% after hours on planned equity offering</a></h4><ul><li>BioCryst Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/BCRX' title='BioCryst Pharmaceuticals, Inc.'>BCRX</a>) slips <font color=\"red\">8%</font> after hours in reaction to its $55M <a href=\"https://seekingalpha.com/pr/17696589-biocryst-commences-public-offering-common-stock\" target=\"_blank\">public offering</a> of common stock. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3518392\" data-linked=\"BioCryst down 8% after hours on planned equity offering\" data-tweet=\"$BCRX - BioCryst down 8% after hours on planned equity offering https://seekingalpha.com/news/3518392-biocryst-down-8-after-hours-on-planned-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3518392-biocryst-down-8-after-hours-on-planned-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518386\" data-ts=\"1573595662\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HIIQ\" target=\"_blank\">HIIQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518386-health-insurance-innovations-down-4-after-hours-on-revenue-guidance-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Health Insurance Innovations down 4% after hours on revenue guidance cut</a></h4><ul><li>Health Insurance Innovations (NASDAQ:<a href='https://seekingalpha.com/symbol/HIIQ' title='Health Insurance Innovations, Inc.'>HIIQ</a>) <a href=\"https://seekingalpha.com/pr/17696727-health-insurance-innovations-inc-reports-third-quarter-2019-results\" target=\"_blank\">Q3 results</a>:</li><li>Revenue: $75.3M (+5%).</li><li>Net income: $4.8M (+220%) (driven by adjustment to deferred tax valuation allowance); EPS: $0.40 (+400%); non-GAAP EPS: $0.66 (+65%); non-GAAP EBITDA: $12.8M (+35%).</li><li><strong>2019 guidance</strong>: Revenue: $400M - 410M from $450M - 460M; non-GAAP EPS: $4.10 - 4.35 from $4.00 - 4.25; non-GAAP EBITDA: $82M - 87M (unch).</li><li>CFO Michael Hershberger will step down November 15 to be succeeded by Erik Helding. Mr. Hershberger will stay on until year-end to assist with the transition.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3518291-health-insurance-innovations-eps-beats-0_34-misses-revenue\" target=\"_blank\">Health Insurance Innovations EPS beats by $0.34, misses on revenue</a> (Nov. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3518386\" data-linked=\"Health Insurance Innovations down 4% after hours on revenue guidance cut\" data-tweet=\"$HIIQ - Health Insurance Innovations down 4% after hours on revenue guidance cut https://seekingalpha.com/news/3518386-health-insurance-innovations-down-4-after-hours-on-revenue-guidance-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3518386-health-insurance-innovations-down-4-after-hours-on-revenue-guidance-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518457\" data-ts=\"1573595542\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IO\" target=\"_blank\">IO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518457-ion-wins-ocean-bottom-data-processing-and-imaging-contract-argas\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ION wins ocean bottom data processing and imaging contract with ARGAS</a></h4><ul><li>ION Geophysical (NYSE:<a href='https://seekingalpha.com/symbol/IO' title='ION Geophysical Corporation'>IO</a>) <font color=\"green\">+4.4%</font> after-hours on news it was <a href=\"https://seekingalpha.com/pr/17696740-ion-awarded-large-two-year-ocean-bottom-data-processing-imaging-contract\" target=\"_blank\">awarded</a> a \"large\" two-year ocean bottom nodal data processing and imaging contract by ARGAS; financial terms are not disclosed.</li><li>ION says it will deliver high-end time and depth imaging to facilitate exploration and production of the acquired area in the Middle East.</li><li>Saudi Arabia's ARGAS is a leading Middle Eastern geosciences company.</li></ul><div class=\"tiny-share-widget\" data-id=\"3518457\" data-linked=\"ION wins ocean bottom data processing and imaging contract with ARGAS\" data-tweet=\"$IO - ION wins ocean bottom data processing and imaging contract with ARGAS https://seekingalpha.com/news/3518457-ion-wins-ocean-bottom-data-processing-and-imaging-contract-argas?source=tweet\" data-url=\"https://seekingalpha.com/news/3518457-ion-wins-ocean-bottom-data-processing-and-imaging-contract-argas\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518370\" data-ts=\"1573595423\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518370-jpmorgan-downgrades-intelsat-on-c-band-complications\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JPMorgan downgrades Intelsat on C-band complications</a></h4><ul>   <li>Intelsat (NYSE:<a href='https://seekingalpha.com/symbol/I' title='Intelsat S.A.'>I</a>) is <font color=\"red\">down 2%</font>, adding to a regular-session decline where it hit a two-month low, following a downgrade by JPMorgan to Neutral from Overweight.</li>    <li>A sale process for C-band spectrum that Intelsat is championing is \"looking more complicated than it seemed only weeks ago,\" the firm says.</li>    <li>That comes after some <a href=\"https://seekingalpha.com/news/3510725-intelsat-turns-house-c-band-hearing-starts\" target=\"_blank\">lawmaker pushback urging a public auction</a> of the mid-band satellite airwaves, which can be monetized for reuse by wireless carriers pushing 5G deployments.</li>    <li>The momentum that idea is getting means a clean win for the C-band satellite companies (including SES (<a href='https://seekingalpha.com/symbol/SGBAF' title='SES S.A.'>OTCPK:SGBAF</a>) and possibly Eutelsat (<a href='https://seekingalpha.com/symbol/EUTLY' title='Eutelsat Communications ADR'>OTCPK:EUTLY</a>)) is less likely, analyst Philip Cusick says. At best, timing is likely to slow down and could delay the availability of the spectrum coming to market.</li>    <li>He's cut his price target on Intelsat to $22 from $34, now implying just 7.9% upside.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3518370\" data-linked=\"JPMorgan downgrades Intelsat on C-band complications\" data-tweet=\"$I $SGBAF $EUTLY - JPMorgan downgrades Intelsat on C-band complications https://seekingalpha.com/news/3518370-jpmorgan-downgrades-intelsat-on-c-band-complications?source=tweet\" data-url=\"https://seekingalpha.com/news/3518370-jpmorgan-downgrades-intelsat-on-c-band-complications\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518353\" data-ts=\"1573595170\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BGNE\" target=\"_blank\">BGNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518353-beigene-q3-product-sales-up-30-cash-consumption-doubles\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BeiGene Q3 product sales up 30%; cash consumption doubles</a></h4><ul><li>BeiGene (NASDAQ:<a href='https://seekingalpha.com/symbol/BGNE' title='BeiGene, Ltd.'>BGNE</a>) <a href=\"https://seekingalpha.com/pr/17696676-beigene-reports-third-quarter-2019-financial-results\" target=\"_blank\">Q3 results</a>:</li><li>Product revenue: $50.1M (+30%). Collaboration revenue dried up due to end of Celgene collaboration on tislelizumab.</li><li>Net loss: ($307.4M) (-113%); loss/share: ($0.39) (-105%).</li><li>Cash consumption: ($265.0M) (-100%).</li><li>Shares down <font color=\"red\">1% </font>after hours.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3518328-beigene-eps-misses-1_07-misses-revenue\" target=\"_blank\">BeiGene EPS misses by $1.07, misses on revenue</a> (Nov. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3518353\" data-linked=\"BeiGene Q3 product sales up 30%; cash consumption doubles\" data-tweet=\"$BGNE - BeiGene Q3 product sales up 30%; cash consumption doubles https://seekingalpha.com/news/3518353-beigene-q3-product-sales-up-30-cash-consumption-doubles?source=tweet\" data-url=\"https://seekingalpha.com/news/3518353-beigene-q3-product-sales-up-30-cash-consumption-doubles\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518344\" data-ts=\"1573594925\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DDOG\" target=\"_blank\">DDOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518344-datadog-3-after-beats-upside-q4-and-fy-views\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Datadog +!3% after beats, upside Q4 and FY views</a></h4><ul><li>Datadog (NASDAQ:<a href='https://seekingalpha.com/symbol/DDOG' title='Datadog, Inc.'>DDOG</a>) <font color=\"green\">+13%</font> beats <a href=\"https://seekingalpha.com/news/3518270-datadog-eps-beats-0_14-beats-revenue\" target=\"_blank\">Q3 estimates</a> in its first report since the <a href=\"https://seekingalpha.com/news/3500526-datadog-plus-49-percent-first-trading-day\" target=\"_blank\">IPO</a> with revenue up 88% Y/Y.</li><li>Upside Q4 guidance sees revenue of $101-103M (consensus: $92.26M) and a loss per share of $0.02-0.01 (consensus: $0.05 loss).</li><li>The FY view has revenue of $350-352M (consensus: $330.2M) and loss per share of $0.12-0.11 (consensus: $0.30 loss).</li><li>Q3 operating margin was 0.7% versus the -15.6% consensus.</li><li>Cash from operations totaled $3.8M with FCF of -$3.7M.</li><li>Cash and equivalents were $771M at the end of the quarter.</li><li>The number of $100K+ ARR customers grew to 727 from last year's 377.</li><li>Earnings call starts at 5 PM ET with a webcast <a href=\"https://investors.datadoghq.com/\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17696724-datadog-announces-third-quarter-2019-results\" target=\"_blank\">Press release</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3518344\" data-linked=\"Datadog +!3% after beats, upside Q4 and FY views\" data-tweet=\"$DDOG - Datadog +!3% after beats, upside Q4 and FY views https://seekingalpha.com/news/3518344-datadog-3-after-beats-upside-q4-and-fy-views?source=tweet\" data-url=\"https://seekingalpha.com/news/3518344-datadog-3-after-beats-upside-q4-and-fy-views\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518338\" data-ts=\"1573594804\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBPX\" target=\"_blank\">CBPX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518338-continental-building-products-oks-37-share-takeover\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Continental Building Products OKs $37/share takeover</a></h4><ul>   <li>Alongside its <a href=\"https://seekingalpha.com/news/3518272-continental-building-products-eps-misses-0_02-beats-revenue\" target=\"_blank\">Q3 earnings</a>, Continental Building Products (NYSE:<a href='https://seekingalpha.com/symbol/CBPX' title='Continental Building Products, Inc.'>CBPX</a>) has <a href=\"https://seekingalpha.com/pr/17696731-continental-building-products-reports-third-quarter-2019-results-announces-agreement-acquired\" target=\"_blank\">agreed to a buyout at $37/share</a>.</li>    <li>The agreement is an all-cash takeover by France's Compagnie de Saint-Gobain, with an enterprise value of $1.4B.</li>      <li>That's a premium of about 34.4% over VWAP during the 60 days ended Nov. 11.</li>   <li>Shares are <font color=\"green\">up 1.5%</font> after hours.</li>   <li>\"We believe our combined business will be better positioned to enhance our product offerings, customer relationships and operating platform,\" Continental execs say.</li>    <li>The company will be merged with and into a new Saint-Gobain subsidiary.</li>    <li>The deal's gotten unanimous board approval.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3518338\" data-linked=\"Continental Building Products OKs $37/share takeover\" data-tweet=\"$CBPX - Continental Building Products OKs $37/share takeover https://seekingalpha.com/news/3518338-continental-building-products-oks-37-share-takeover?source=tweet\" data-url=\"https://seekingalpha.com/news/3518338-continental-building-products-oks-37-share-takeover\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518323\" data-ts=\"1573594301\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VLRX\" target=\"_blank\">VLRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518323-valeritas-eps-beats-0_66-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valeritas EPS beats by $0.66, misses on revenue</a></h4><ul><li>Valeritas (NASDAQ:<a href='https://seekingalpha.com/symbol/VLRX' title='Valeritas Holdings, Inc.'>VLRX</a>): Q3 GAAP EPS of -$1.91 <font color=\"green\">beats by $0.66</font>.</li><li>Revenue of $8.46M (+22.1% Y/Y) <font color=\"red\">misses by $0.04M</font>.</li><li>Shares <font color=\"green\">+4.67%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17696651-valeritas-announces-third-quarter-2019-financial-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3518323\" data-linked=\"Valeritas EPS beats by $0.66, misses on revenue\" data-tweet=\"$VLRX - Valeritas EPS beats by $0.66, misses on revenue https://seekingalpha.com/news/3518323-valeritas-eps-beats-0_66-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3518323-valeritas-eps-beats-0_66-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:31 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518318\" data-ts=\"1573594182\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SWKS\" target=\"_blank\">SWKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518318-skyworksminus-4-despite-beats-upside-eps-view\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Skyworks -4% despite beats, upside EPS view</a></h4><ul><li>Skyworks Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/SWKS' title='Skyworks Solutions, Inc.'>SWKS</a>) <font color=\"red\">-3.9%</font> <a href=\"https://seekingalpha.com/news/3518274-skyworks-solutions-eps-beats-0_02-beats-revenue\" target=\"_blank\">beats Q4</a> Street estimates despite an 18% Y/Y drop in revenue. The Q1 outlook has in-line revenue of $870-890M and upside EPS of $1.65 versus the $1.60 estimate.</li><li>Gross margin was 50.3% (matching consensus) compared to the 51.2% in last year's quarter.</li><li>Operating expenses rose from $163.5M in last year's quarter to $172.1M.</li><li>SWKS ended the period with cash and equivalents of $851.3M.</li><li>Earnings call starts at 5 PM with a webcast <a href=\"https://investors.skyworksinc.com/investor-relations\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17696746-skyworks-reports-q4-full-year-fy19-results\" target=\"_blank\">Press release</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3518318\" data-linked=\"Skyworks -4% despite beats, upside EPS view\" data-tweet=\"$SWKS - Skyworks -4% despite beats, upside EPS view https://seekingalpha.com/news/3518318-skyworksminus-4-despite-beats-upside-eps-view?source=tweet\" data-url=\"https://seekingalpha.com/news/3518318-skyworksminus-4-despite-beats-upside-eps-view\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518301\" data-ts=\"1573593870\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HTGM\" target=\"_blank\">HTGM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518301-htg-molecular-eps-misses-0_01-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HTG Molecular EPS misses by $0.01, misses on revenue</a></h4><ul><li>HTG Molecular (NASDAQ:<a href='https://seekingalpha.com/symbol/HTGM' title='HTG Molecular Diagnostics, Inc.'>HTGM</a>): Q3 GAAP EPS of -$0.15 <font color=\"red\">misses by $0.01</font>.</li><li>Revenue of $5.4M (+14.6% Y/Y) <font color=\"red\">misses by $0.07M</font>.</li><li>Shares <font color=\"green\">+2.5%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17696582-htg-molecular-diagnostics-reports-third-quarter-2019-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3518301\" data-linked=\"HTG Molecular EPS misses by $0.01, misses on revenue\" data-tweet=\"$HTGM - HTG Molecular EPS misses by $0.01, misses on revenue https://seekingalpha.com/news/3518301-htg-molecular-eps-misses-0_01-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3518301-htg-molecular-eps-misses-0_01-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518298\" data-ts=\"1573593819\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VTSI\" target=\"_blank\">VTSI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518298-virtra-eps-beats-0_13-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VirTra EPS beats by $0.13, beats on revenue</a></h4><ul><li>VirTra (NASDAQ:<a href='https://seekingalpha.com/symbol/VTSI' title='VirTra, Inc.'>VTSI</a>): Q3 GAAP EPS of $0.12 <font color=\"green\">beats by $0.13</font>.</li><li>Revenue of $6.71M (+89.0% Y/Y) <font color=\"green\">beats by $2.24M</font>.</li><li>Shares <font color=\"green\">+18.67%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17696661-virtra-reports-third-quarter-nine-month-2019-financial-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3518298\" data-linked=\"VirTra EPS beats by $0.13, beats on revenue\" data-tweet=\"$VTSI - VirTra EPS beats by $0.13, beats on revenue https://seekingalpha.com/news/3518298-virtra-eps-beats-0_13-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3518298-virtra-eps-beats-0_13-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518297\" data-ts=\"1573593777\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NBRV\" target=\"_blank\">NBRV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518297-nabriva-therapeutics-eps-beats-0_04-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nabriva Therapeutics EPS beats by $0.04, beats on revenue</a></h4><ul><li>Nabriva Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/NBRV' title='Nabriva Therapeutics plc'>NBRV</a>): Q3 GAAP EPS of -$0.24 <font color=\"green\">beats by $0.04</font>.</li><li>Revenue of $6.92M (+1404.3% Y/Y) <font color=\"green\">beats by $6.39M</font>.</li><li>Shares <font color=\"green\">+5.05%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17696591-nabriva-therapeutics-reports-third-quarter-2019-financial-results-recent-corporate-highlights\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3518297\" data-linked=\"Nabriva Therapeutics EPS beats by $0.04, beats on revenue\" data-tweet=\"$NBRV - Nabriva Therapeutics EPS beats by $0.04, beats on revenue https://seekingalpha.com/news/3518297-nabriva-therapeutics-eps-beats-0_04-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3518297-nabriva-therapeutics-eps-beats-0_04-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518296\" data-ts=\"1573593745\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSIQ\" target=\"_blank\">CSIQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518296-canadian-solar-slips-revenues-tumble-24-q-q\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canadian Solar slips as revenues tumble 24% Q/Q</a></h4><ul><li>Canadian Solar (NASDAQ:<a href='https://seekingalpha.com/symbol/CSIQ' title='Canadian Solar Inc.'>CSIQ</a>) <font color=\"red\">-14.1%</font> after-hours after missing estimates for <a href=\"https://seekingalpha.com/news/3518221-canadian-solar-eps-misses-0_02-misses-revenue\" target=\"_blank\">Q3 earnings</a> and revenues, which fell 24% Q/Q to $760M from $1B in Q2 and came in below company guidance of $780M-$810M, reflecting lower revenue from the sale of solar power plants.</li><li>Q3 solar module shipments rose 11% Q/Q to 2,387 MW from 2,143 MW and above guidance of 2.2-2.3  GW.</li><li>Q3 gross margin was 26.2%, or 23% excluding a $24.3M countervailing duty true-up benefit, vs. 17.6% in Q2, 26.1% in the year-ago quarter and company guidance of 24%-26%.</li><li>Net cash provided by operating activities tumbled to $22.4M in the quarter from $225.8M in Q2.</li><li>For Q4, CSIQ expects total solar module shipments of 2.3-2.4 GW, including 190 MW of shipments  to utility-scale solar power projects that may not be recognized as  revenue in the quarter, while Q4 revenues are forecast at $850M-$880M, well below $1.3B analyst consensus estimate.</li><li>As of Sept. 30, the company's late-stage, utility-scale solar project pipeline, including those in construction, totaled ~3.4 GWp.</li></ul><div class=\"tiny-share-widget\" data-id=\"3518296\" data-linked=\"Canadian Solar slips as revenues tumble 24% Q/Q\" data-tweet=\"$CSIQ - Canadian Solar slips as revenues tumble 24% Q/Q https://seekingalpha.com/news/3518296-canadian-solar-slips-revenues-tumble-24-q-q?source=tweet\" data-url=\"https://seekingalpha.com/news/3518296-canadian-solar-slips-revenues-tumble-24-q-q\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518294\" data-ts=\"1573593736\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LCTX\" target=\"_blank\">LCTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518294-biotime-eps-misses-0_06-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioTime EPS misses by $0.06, misses on revenue</a></h4><ul><li>BioTime (NYSEMKT:<a href='https://seekingalpha.com/symbol/LCTX' title='Lineage Cell Therapeutics, Inc.'>LCTX</a>): Q3 GAAP EPS of -$0.11 <font color=\"red\">misses by $0.06</font>.</li><li>Revenue of $0.57M (-41.8% Y/Y) <font color=\"red\">misses by $0.24M</font>.</li><li>Shares <font color=\"green\">+3.1%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17696666-lineage-cell-therapeutics-reports-third-quarter-2019-financial-results-provides-business\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3518294\" data-linked=\"BioTime EPS misses by $0.06, misses on revenue\" data-tweet=\"$LCTX - BioTime EPS misses by $0.06, misses on revenue https://seekingalpha.com/news/3518294-biotime-eps-misses-0_06-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3518294-biotime-eps-misses-0_06-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518292\" data-ts=\"1573593681\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SDC\" target=\"_blank\">SDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518292-smiledirectclub-q3-top-line-up-51-loss-widens-shares-2-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SmileDirectClub Q3 top line up 51% but loss widens; shares 2% after hours</a></h4><ul><li>SmileDirectClub (NASDAQ:<a href='https://seekingalpha.com/symbol/SDC' title='SmileDirectClub, Inc.'>SDC</a>) <a href=\"https://seekingalpha.com/pr/17696674-smile-direct-club-reports-third-quarter-2019-financial-results\" target=\"_blank\">Q3 results</a>:</li><li>Revenues: $180.2M (+51%).</li><li>Align shipments: 106,070 (+47%); average selling price: $1,788 (+1%).</li><li>Net loss: ($387.1M) (-999%); loss/share: ($0.89); non-GAAP EBITDA: ($45.2M) (-999%).</li><li>Cash flow ops (9 mo.): ($192.0M) (-131%).</li><li><strong>2019 guidance</strong>: Revenues: $750M - 755M; non-GAAP EBITDA: ($80M - 73M).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3518306-smiledirectclub-eps-beats-0_10-beats-revenue\" target=\"_blank\">SmileDirectClub EPS beats by $0.10, beats on revenue</a> (Nov. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3518292\" data-linked=\"SmileDirectClub Q3 top line up 51% but loss widens; shares 2% after hours\" data-tweet=\"$SDC - SmileDirectClub Q3 top line up 51% but loss widens; shares 2% after hours https://seekingalpha.com/news/3518292-smiledirectclub-q3-top-line-up-51-loss-widens-shares-2-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3518292-smiledirectclub-q3-top-line-up-51-loss-widens-shares-2-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518270\" data-ts=\"1573593284\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DDOG\" target=\"_blank\">DDOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518270-datadog-eps-beats-0_14-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Datadog EPS beats by $0.14, beats on revenue</a></h4><ul><li>Datadog (NASDAQ:<a href='https://seekingalpha.com/symbol/DDOG' title='Datadog, Inc.'>DDOG</a>): Q3 Non-GAAP EPS of $0.00 <font color=\"green\">beats by $0.14</font>; GAAP EPS of -$0.04 <font color=\"green\">beats by $0.15</font>.</li><li>Revenue of $95.9M (+87.8% Y/Y) <font color=\"green\">beats by $11.24M</font>.</li><li>Shares <font color=\"green\">+11%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17696724-datadog-announces-third-quarter-2019-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3518270\" data-linked=\"Datadog EPS beats by $0.14, beats on revenue\" data-tweet=\"$DDOG - Datadog EPS beats by $0.14, beats on revenue https://seekingalpha.com/news/3518270-datadog-eps-beats-0_14-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3518270-datadog-eps-beats-0_14-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518262\" data-ts=\"1573593208\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HCAT\" target=\"_blank\">HCAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518262-health-catalyst-eps-beats-0_10-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Health Catalyst EPS beats by $0.10, beats on revenue</a></h4><ul><li>Health Catalyst (NASDAQ:<a href='https://seekingalpha.com/symbol/HCAT' title='Health Catalyst, Inc.'>HCAT</a>): Q3 Non-GAAP EPS of -$0.27 <font color=\"green\">beats by $0.10</font>; GAAP EPS of -$1.40 <font color=\"red\">misses by $0.98</font>.</li><li>Revenue of $39.42M (+19.9% Y/Y) <font color=\"green\">beats by $1.65M</font>.</li><li>Shares <font color=\"green\">+1.3%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17696730-health-catalyst-reports-third-quarter-2019-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3518262\" data-linked=\"Health Catalyst EPS beats by $0.10, beats on revenue\" data-tweet=\"$HCAT - Health Catalyst EPS beats by $0.10, beats on revenue https://seekingalpha.com/news/3518262-health-catalyst-eps-beats-0_10-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3518262-health-catalyst-eps-beats-0_10-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518260\" data-ts=\"1573593162\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWOU\" target=\"_blank\">TWOU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518260-2uplus-11_5-after-upside-fy-revenue-view\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">2U +11.5% after upside FY revenue view</a></h4><ul><li>2U (NASDAQ:<a href='https://seekingalpha.com/symbol/TWOU' title='2U, Inc.'>TWOU</a>) <font color=\"green\">+11.5%</font> reports <a href=\"https://seekingalpha.com/news/3518217-2u-eps-beats-0_09-beats-revenue\" target=\"_blank\">Q3 beats</a> with 44% revenue growth and upside FY19 guidance that sees revenue of $570-575M and adjusted net loss of $78.5-72.5M.</li><li>Q3 Graduate Program revenue was up 15% Y/Y to $103.4M. Alternative Credential grew 192% to $50.4M.</li><li>Enrollments totaled 40,910 for Graduate and 14,729 for Alternative, both beating consensus.</li><li>Average revenue per enrollment was $2,527 for Graduate (consensus: $2,645) and $3,825 for Alternative (consensus: $3,539).</li><li>The net loss increased from $131.2M to $141.1M.</li><li>Earnings call starts at 5 PM ET with a webcast <a href=\"http://investor.2u.com/\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17696554-2u-inc-reports-results-third-quarter-2019\" target=\"_blank\">Press release</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3518260\" data-linked=\"2U +11.5% after upside FY revenue view\" data-tweet=\"$TWOU - 2U +11.5% after upside FY revenue view https://seekingalpha.com/news/3518260-2uplus-11_5-after-upside-fy-revenue-view?source=tweet\" data-url=\"https://seekingalpha.com/news/3518260-2uplus-11_5-after-upside-fy-revenue-view\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518245\" data-ts=\"1573593008\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HALO\" target=\"_blank\">HALO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518245-halozyme-q3-top-line-up-80-guidance-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Halozyme Q3 top line up 80%, guidance cut</a></h4><ul><li>Halozyme (NASDAQ:<a href='https://seekingalpha.com/symbol/HALO' title='Halozyme Therapeutics, Inc.'>HALO</a>) <a href=\"https://seekingalpha.com/pr/17696575-halozyme-reports-third-quarter-2019-results\" target=\"_blank\">Q3 results</a>:</li><li>Revenues: $46.2M (+80%) increase mainly due to bulk rHuPH20 sales to Janssen of $20.1M.</li><li>Net loss: ($25.0M) (+10%); loss/share: ($0.17) (+11%).</li><li><strong>2019 guidance</strong>: Revenues: $195M -205M from $205M - 215M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3518229-halozyme-therapeutics-eps-misses-0_05-misses-revenue\" target=\"_blank\">Halozyme Therapeutics EPS misses by $0.05, misses on revenue</a> (Nov. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3518245\" data-linked=\"Halozyme Q3 top line up 80%, guidance cut\" data-tweet=\"$HALO - Halozyme Q3 top line up 80%, guidance cut https://seekingalpha.com/news/3518245-halozyme-q3-top-line-up-80-guidance-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3518245-halozyme-q3-top-line-up-80-guidance-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518243\" data-ts=\"1573592971\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RUN\" target=\"_blank\">RUN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518243-sunrun-eps-beats-0_19-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sunrun EPS beats by $0.19, beats on revenue</a></h4><ul><li>Sunrun (NASDAQ:<a href='https://seekingalpha.com/symbol/RUN' title='Sunrun Inc.'>RUN</a>): Q3 GAAP EPS of $0.23 <font color=\"green\">beats by $0.19</font>.</li><li>Revenue of $215.5M (+5.1% Y/Y) <font color=\"green\">beats by $8.28M</font>.</li><li>Shares <font color=\"green\">+4%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17696685-sunrun-reports-third-quarter-2019-financial-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3518243\" data-linked=\"Sunrun EPS beats by $0.19, beats on revenue\" data-tweet=\"$RUN - Sunrun EPS beats by $0.19, beats on revenue https://seekingalpha.com/news/3518243-sunrun-eps-beats-0_19-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3518243-sunrun-eps-beats-0_19-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518219\" data-ts=\"1573592643\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BDSI\" target=\"_blank\">BDSI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518219-biodelivery-sciences-eps-beats-0_02-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioDelivery Sciences EPS beats by $0.02, beats on revenue</a></h4><ul><li>BioDelivery Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/BDSI' title='BioDelivery Sciences International, Inc.'>BDSI</a>): Q3 GAAP EPS of $0.00 <font color=\"green\">beats by $0.02</font>.</li><li>Revenue of $30.3M (+114.9% Y/Y) <font color=\"green\">beats by $2.02M</font>.</li><li>Shares <font color=\"green\">+1.2%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17696572-biodelivery-sciences-reports-strong-third-quarter-results-raises-full-year-2019-provides-2020\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3518219\" data-linked=\"BioDelivery Sciences EPS beats by $0.02, beats on revenue\" data-tweet=\"$BDSI - BioDelivery Sciences EPS beats by $0.02, beats on revenue https://seekingalpha.com/news/3518219-biodelivery-sciences-eps-beats-0_02-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3518219-biodelivery-sciences-eps-beats-0_02-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518217\" data-ts=\"1573592595\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWOU\" target=\"_blank\">TWOU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518217-2u-eps-beats-0_09-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">2U EPS beats by $0.09, beats on revenue</a></h4><ul><li>2U (NASDAQ:<a href='https://seekingalpha.com/symbol/TWOU' title='2U, Inc.'>TWOU</a>): Q3 Non-GAAP EPS of -$0.41 <font color=\"green\">beats by $0.09</font>; GAAP EPS of -$2.23 <font color=\"red\">misses by $1.15</font>.</li><li>Revenue of $153.8M (+43.8% Y/Y) <font color=\"green\">beats by $3.96M</font>.</li><li>Shares <font color=\"green\">+7%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17696554-2u-inc-reports-results-third-quarter-2019\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3518217\" data-linked=\"2U EPS beats by $0.09, beats on revenue\" data-tweet=\"$TWOU - 2U EPS beats by $0.09, beats on revenue https://seekingalpha.com/news/3518217-2u-eps-beats-0_09-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3518217-2u-eps-beats-0_09-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518207\" data-ts=\"1573591305\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSX\" target=\"_blank\">CSX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518207-csx-cut-to-hold-deutsche-bank-on-lower-coal-shipments-pricing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CSX cut to Hold at Deutsche Bank on lower coal shipments, pricing</a></h4><ul><li>CSX Corp. (<a href='https://seekingalpha.com/symbol/CSX' title='CSX Corporation'>CSX</a> <font color='red'>-1.8%</font>) drags railroad names lower after Deutsche Bank <a href=\"https://www.marketwatch.com/story/csxs-stock-drops-after-deutsche-bank-downgrades-cuts-price-target-2019-11-12\" target=\"_blank\">downgrades</a> shares to Hold from Buy and cut the stock price target to $74 from $82, citing concerns over lower 2020 revenue and margin headwinds from lower coal shipments and pricing.</li><li>Mehrotra is particularly concerned over exports of metallurgical coal, whose prices are more than 30% lower YTD.</li><li>\"Our top line and cost estimates imply it will be difficult for CSX to expand margins in 2020, reflecting almost superhuman margin performance by management to date... and above-mentioned headwinds in coal (most of which we expect to be price-led and drop to the bottom line),\" Mehrotra writes.</li><li>Also lower: <a href='https://seekingalpha.com/symbol/NSC' title='Norfolk Southern Corporation'>NSC</a> <font color=\"red\">-0.6%</font>, <a href='https://seekingalpha.com/symbol/UNP' title='Union Pacific Corporation'>UNP</a> <font color=\"red\">-0.9%</font>, <a href='https://seekingalpha.com/symbol/KSU' title='Kansas City Southern'>KSU</a> <font color=\"red\">-0.6%</font>.</li><li>CSX's average <a href=\"https://seekingalpha.com/symbol/CSX/ratings/sell-side-ratings\" target=\"_blank\">Sell Side Rating</a> is Neutral, while its <a href=\"https://seekingalpha.com/symbol/CSX/ratings/author-ratings#filter=all\" target=\"_blank\">Seeking Alpha Authors Rating</a> and <a href=\"https://seekingalpha.com/symbol/CSX/ratings/quant-ratings\" target=\"_blank\">Quant Rating</a> are Bullish.</li></ul><div class=\"tiny-share-widget\" data-id=\"3518207\" data-linked=\"CSX cut to Hold at Deutsche Bank on lower coal shipments, pricing\" data-tweet=\"$CSX $NSC $UNP - CSX cut to Hold at Deutsche Bank on lower coal shipments, pricing https://seekingalpha.com/news/3518207-csx-cut-to-hold-deutsche-bank-on-lower-coal-shipments-pricing?source=tweet\" data-url=\"https://seekingalpha.com/news/3518207-csx-cut-to-hold-deutsche-bank-on-lower-coal-shipments-pricing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518205\" data-ts=\"1573590675\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVET\" target=\"_blank\">CVET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518205-covetrus-up-22-after-q3-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Covetrus up 22% after Q3 beat</a></h4><ul><li>Covetrus (<a href='https://seekingalpha.com/symbol/CVET' title='Covetrus, Inc.'>CVET</a> <font color=\"green\">+21.5%</font>), the combination of Henry Schein's (<a href='https://seekingalpha.com/symbol/HSIC' title='Henry Schein, Inc.'>HSIC</a> <font color=\"green\">+0.6%</font>) animal health business and Vets First Choice, is up on double normal after its <a href=\"https://seekingalpha.com/pr/17695086-covetrus-announces-financial-results-third-quarter-2019\" target=\"_blank\">Q3 report</a>. Highlights:</li><li>On a pro forma basis: Sales up 10% to $1,018M; non-GAAP EBITDA: $49M (-4%); non-GAAP net income: $19M (-10%).</li><li><strong>2019 guidance</strong>: Pro forma organic sales growth: low single-digit (unch); pro forma non-GAAP EBITDA: $190M - 196M from at least $200M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3517868-covetrus-eps-8_09\" target=\"_blank\">Covetrus EPS of -$8.09</a> (Nov. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3518205\" data-linked=\"Covetrus up 22% after Q3 beat\" data-tweet=\"$CVET $HSIC - Covetrus up 22% after Q3 beat https://seekingalpha.com/news/3518205-covetrus-up-22-after-q3-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3518205-covetrus-up-22-after-q3-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518202\" data-ts=\"1573589825\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SQM\" target=\"_blank\">SQM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518202-escalating-protests-sink-chilean-stocks-currency\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Escalating protests sink Chilean stocks, currency</a></h4><ul><li>Chilean-based stocks are hit hard and the peso falls to a historic low amid <a href=\"https://www.reuters.com/article/us-chile-protests/no-end-in-sight-to-chile-unrest-as-massive-strike-more-protests-planned-idUSKBN1XM1SG\" target=\"_blank\">escalating demonstrations</a> and protests in the country.</li><li>Chile's currency plunged to more than 800 pesos per dollar, down more than 10% since mid-October, but the central bank president says the country's fiscal situation remains \"solid.\"</li><li>Among major stocks: <a href='https://seekingalpha.com/symbol/SQM' title='Sociedad Química y Minera de Chile S.A.'>SQM</a> <font color=\"red\">-8.4%</font>, <a href='https://seekingalpha.com/symbol/ALB' title='Albemarle Corporation'>ALB</a> <font color=\"red\">-3.8%</font>, <a href='https://seekingalpha.com/symbol/BCH' title='Banco de Chile'>BCH</a> <font color=\"red\">-6.5%</font>, <a href='https://seekingalpha.com/symbol/BSAC' title='Banco Santander-Chile'>BSAC</a> <font color=\"red\">-4.6%</font>, <a href='https://seekingalpha.com/symbol/LTM' title='LATAM Airlines Group S.A.'>LTM</a> <font color=\"red\">-3.1%</font>, <a href='https://seekingalpha.com/symbol/CCU' title='Compañía Cervecerías Unidas S.A.'>CCU</a> <font color=\"red\">-3%</font>, <a href='https://seekingalpha.com/symbol/ENIA' title='Enel Américas S.A.'>ENIA</a> <font color=\"red\">-2.1%</font>, <a href='https://seekingalpha.com/symbol/AKO.A' title='Embotelladora Andina S.A.'>AKO.A</a> <font color=\"red\">-14.4%</font>.</li><li>State workers and some unionized miners in Chile launched a nationwide walkout today, saying they were not satisfied  by the government's pledge to rewrite the country's criticized dictatorship-era constitution.</li><li>But the announcement has <a href=\"https://www.bnnbloomberg.ca/national-strike-shows-the-strength-and-limits-of-chilean-protests-1.1346851\" target=\"_blank\">created a near-panic in financial markets</a>, which fear a new  constitution would undermine the free market policies that have made Chile one of South America's wealthier economies.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/ECH' title='iShares MSCI Chile Capped ETF'>ECH</a>, <a href='https://seekingalpha.com/symbol/CH' title='Aberdeen Chile Fund'>CH</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3518202\" data-linked=\"Escalating protests sink Chilean stocks, currency\" data-tweet=\"$SQM $ALB $BCH - Escalating protests sink Chilean stocks, currency https://seekingalpha.com/news/3518202-escalating-protests-sink-chilean-stocks-currency?source=tweet\" data-url=\"https://seekingalpha.com/news/3518202-escalating-protests-sink-chilean-stocks-currency\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>41&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518197\" data-ts=\"1573588931\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518197-dxc-ebix-cvet-and-tme-among-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DXC, EBIX, CVET and TME among tech movers</a></h4><ul><li><strong>Gainers: </strong>Applied DNA Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/APDN' title='Applied DNA Sciences, Inc.'>APDN</a>) <font color=\"green\">+200%</font>.</li><li>Covetrus (NASDAQ:<a href='https://seekingalpha.com/symbol/CVET' title='Covetrus, Inc.'>CVET</a>) <font color=\"green\">+22%</font>.</li><li>Sea Limited (NYSE:<a href='https://seekingalpha.com/symbol/SE' title='Sea Limited'>SE</a>) <font color=\"green\">+18%</font>.</li><li>DXC Technology Company (NYSE:<a href='https://seekingalpha.com/symbol/DXC' title='DXC Technology Company'>DXC</a>) <font color=\"green\">+17%</font>.</li><li>Synchronoss Technologies, Inc. (NASDAQ:<a href='https://seekingalpha.com/symbol/SNCR' title='Synchronoss Technologies, Inc.'>SNCR</a>) <font color=\"green\">+14%</font>.</li> <li><strong>Losers:</strong> NetSol Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/NTWK' title='NetSol Technologies, Inc.'>NTWK</a>) <font color=\"red\">-16%</font>.</li><li>GTT Communications (NYSE:<a href='https://seekingalpha.com/symbol/GTT' title='GTT Communications, Inc.'>GTT</a>) <font color=\"red\">-16%</font>.</li><li>Ebix (NASDAQ:<a href='https://seekingalpha.com/symbol/EBIX' title='Ebix, Inc.'>EBIX</a>) <font color=\"red\">-11%</font>.</li><li>Uxin Limited (NASDAQ:<a href='https://seekingalpha.com/symbol/UXIN' title='Uxin Limited'>UXIN</a>) <font color=\"red\">-9%</font>.</li><li>Tencent Music Entertainment Group (NYSE:<a href='https://seekingalpha.com/symbol/TME' title='Tencent Music Entertainment Group'>TME</a>) <font color=\"red\">-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3518197\" data-linked=\"DXC, EBIX, CVET and TME among tech movers\" data-tweet=\"$APDN $CVET $SE - DXC, EBIX, CVET and TME among tech movers https://seekingalpha.com/news/3518197-dxc-ebix-cvet-and-tme-among-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3518197-dxc-ebix-cvet-and-tme-among-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518195\" data-ts=\"1573587779\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518195-ftnt-vrnt-gain-bull-returns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FTNT, VRNT gain as bull returns</a></h4><ul><li>Goldman resumes coverage on Fortinet (NASDAQ:<a href='https://seekingalpha.com/symbol/FTNT' title='Fortinet, Inc.'>FTNT</a>) with a Buy rating and $113 target, an 18% upside.</li><li>The firm also reinstates Verint Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/VRNT' title='Verint Systems Inc.'>VRNT</a>) at Buy and $58, a 21% upside.</li><li>Analyst Brian Essex: \"Within our coverage universe, we prefer stocks of companies with favorable exposure to next-generation security, an ability to take share in key markets, a demonstrated ability to execute, and strong fundamentals with cash flow.\"</li><li>High-growth software stocks have pulled back in the past few months, but Essex thinks the market will continue to reward \"share gainers in the market with a premium to peers.\"</li><li>Fortinet shares are <font color=\"green\">up 3.8%</font> to $99.60. The company has a Bullish average <a href=\"https://seekingalpha.com/symbol/FTNT/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li><li>Verint is <font color=\"green\">up 1.4%</font> to $48.43 and also has a Bullish <a href=\"https://seekingalpha.com/symbol/VRNT/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3518195\" data-linked=\"FTNT, VRNT gain as bull returns\" data-tweet=\"$FTNT $VRNT - FTNT, VRNT gain as bull returns https://seekingalpha.com/news/3518195-ftnt-vrnt-gain-bull-returns?source=tweet\" data-url=\"https://seekingalpha.com/news/3518195-ftnt-vrnt-gain-bull-returns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518191\" data-ts=\"1573586900\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SVM\" target=\"_blank\">SVM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518191-silvercorp-metals-cut-alliance-global-on-valuation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Silvercorp Metals cut by Alliance Global on valuation</a></h4><ul><li>Silvercorp Metals (<a href='https://seekingalpha.com/symbol/SVM' title='Silvercorp Metals Inc.'>SVM</a> <font color='green'>+2.8%</font>) moves higher despite getting <a href=\"https://www.streetinsider.com/Downgrades/Alliance+Global+Partners+Downgrades+Silvercorp+Metals+%28SVM%29+to+Hold/16120361.html\" target=\"_blank\">downgraded</a> to Neutral from Buy on valuation by Alliance Global Partners.</li><li>\"An upward revision to the grades and recoveries has increased our life of mine production estimates at both the Ying mine and the GC mine,\" Alliance's Bhakti Pavani writes, lifting the firm's net asset value estimate for SVM to $748M ($4.35/share) from $725M ($4.25/share).</li><li>But Pavani thinks SVM is now fairly valued, as it trades above the firm's revised NAV estimate, which assumes a discount rate of 7% and uses a flat, long-term benchmark price of silver, lead, and zinc of $20/oz. Ag, $1/lb. Pb and $1.3/lb. Zn.</li><li>SVM's average <a href=\"https://seekingalpha.com/symbol/SVM/ratings/sell-side-ratings\" target=\"_blank\">Sell Side Rating</a> and <a href=\"https://seekingalpha.com/symbol/SVM/ratings/author-ratings#filter=all\" target=\"_blank\">Seeking Alpha Authors Rating</a> are Bullish, while its <a href=\"https://seekingalpha.com/symbol/SVM/ratings/quant-ratings\" target=\"_blank\">Quant Rating</a> is Neutral.</li></ul><div class=\"tiny-share-widget\" data-id=\"3518191\" data-linked=\"Silvercorp Metals cut by Alliance Global on valuation\" data-tweet=\"$SVM - Silvercorp Metals cut by Alliance Global on valuation https://seekingalpha.com/news/3518191-silvercorp-metals-cut-alliance-global-on-valuation?source=tweet\" data-url=\"https://seekingalpha.com/news/3518191-silvercorp-metals-cut-alliance-global-on-valuation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518188\" data-ts=\"1573586350\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELF\" target=\"_blank\">ELF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518188-m-speculation-sends-e-l-f-beauty-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">M&amp;A speculation sends e.l.f. Beauty higher</a></h4><ul><li>Shares of e.l.f. Beauty (<a href='https://seekingalpha.com/symbol/ELF' title='e.l.f. Beauty, Inc.'>ELF</a> <font color='green'>+6.8%</font>) jump after D.A. Davidson points to M&amp;A potential with the cosmetics retailer.</li><li>The firm thinks e.l.f. could fetch $33 per share in a takeover scenario.</li><li>The 52-week high for ELF is $19.96.</li></ul><div class=\"tiny-share-widget\" data-id=\"3518188\" data-linked=\"M&amp;A speculation sends e.l.f. Beauty higher\" data-tweet=\"$ELF - M&amp;A speculation sends e.l.f. Beauty higher https://seekingalpha.com/news/3518188-m-speculation-sends-e-l-f-beauty-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3518188-m-speculation-sends-e-l-f-beauty-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518180\" data-ts=\"1573585886\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518180-twilio-goes-negative-on-report-whatsapp-scaling-down\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Twilio goes negative on report WhatsApp scaling down</a></h4><ul>   <li>After healthy morning gains, Twilio (NYSE:<a href='https://seekingalpha.com/symbol/TWLO' title='Twilio Inc.'>TWLO</a>) has quickly dropped into the red (<font color=\"red\">down 0.7%</font>) amid chatter that its largest customer will scale back usage.</li>    <li>WhatsApp (NASDAQ:<a href='https://seekingalpha.com/symbol/FB' title='Facebook, Inc.'>FB</a>) is responsible for Twilio's biggest share and multiple reports are circulating that it's cutting back.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3518180\" data-linked=\"Twilio goes negative on report WhatsApp scaling down\" data-tweet=\"$TWLO $FB - Twilio goes negative on report WhatsApp scaling down https://seekingalpha.com/news/3518180-twilio-goes-negative-on-report-whatsapp-scaling-down?source=tweet\" data-url=\"https://seekingalpha.com/news/3518180-twilio-goes-negative-on-report-whatsapp-scaling-down\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>53&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518178\" data-ts=\"1573585828\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FGEN\" target=\"_blank\">FGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518178-fibrogen-adds-to-selloff-down-5-on-bearish-muddy-waters-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FibroGen adds to selloff, down 5% on bearish Muddy Waters report</a></h4><ul><li>Embattled FibroGen (<a href='https://seekingalpha.com/symbol/FGEN' title='FibroGen, Inc.'>FGEN</a> <font color=\"red\">-4.5%</font>) is down again today on a 4x surge in volume, adding to longs' misery after yesterday's <font color=\"red\">15%</font> drop.</li><li><a href=\"https://www.muddywatersresearch.com/\" target=\"_blank\">Muddy Waters Research</a> added fuel to roxadustat safety profile-stoked worries with a short <a href=\"https://buyersstrike.files.wordpress.com/2019/11/fgen-notes.pdf\" target=\"_blank\">report </a>published today on BuyersStrike that asserted the company under-reported deaths in a late-stage study.</li><li>Related ticker: AstraZeneca (<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca PLC'>AZN</a> <font color='green'>+0.6%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3518178\" data-linked=\"FibroGen adds to selloff, down 5% on bearish Muddy Waters report\" data-tweet=\"$FGEN $AZN - FibroGen adds to selloff, down 5% on bearish Muddy Waters report https://seekingalpha.com/news/3518178-fibrogen-adds-to-selloff-down-5-on-bearish-muddy-waters-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3518178-fibrogen-adds-to-selloff-down-5-on-bearish-muddy-waters-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518172\" data-ts=\"1573585405\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518172-pedevco-and-ferro-among-energy-materials-gainers-chesapeake-energy-and-fts-international\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PEDEVCO and Ferro among Energy/Materials gainers; Chesapeake Energy and FTS International among losers</a></h4><ul><li><b>Gainers: </b>PEDEVCO (NYSEMKT:<a href='https://seekingalpha.com/symbol/PED' title='PEDEVCO Corp.'>PED</a>) <font color=\"green\">+17%</font>. Ferro (NYSE:<a href='https://seekingalpha.com/symbol/FOE' title='Ferro Corporation'>FOE</a>) <font color=\"green\">+11%</font>. Flotek Industries (NYSE:<a href='https://seekingalpha.com/symbol/FTK' title='Flotek Industries, Inc.'>FTK</a>) <font color=\"green\">+11%</font>. TimkenSteel (NYSE:<a href='https://seekingalpha.com/symbol/TMST' title='TimkenSteel Corporation'>TMST</a>) <font color=\"green\">+8%</font>. Venator Materials (NYSE:<a href='https://seekingalpha.com/symbol/VNTR' title='Venator Materials PLC'>VNTR</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Chesapeake Energy (NYSE:<a href='https://seekingalpha.com/symbol/CHK' title='Chesapeake Energy Corporation'>CHK</a>) <font color=\"red\">-16%</font>. FTS International (NYSE:<a href='https://seekingalpha.com/symbol/FTSI' title='FTS International, Inc.'>FTSI</a>) <font color=\"red\">-11%</font>. Hudbay Minerals (NYSE:<a href='https://seekingalpha.com/symbol/HBM' title='Hudbay Minerals Inc.'>HBM</a>) <font color=\"red\">-9%</font>. Tidewater (NYSE:<a href='https://seekingalpha.com/symbol/TDW' title='Tidewater Inc.'>TDW</a>) <font color=\"red\">-9%</font>. Forum Energy Technologies (NYSE:<a href='https://seekingalpha.com/symbol/FET' title='Forum Energy Technologies, Inc.'>FET</a>) <font color=\"red\">-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3518172\" data-linked=\"PEDEVCO and Ferro among Energy/Materials gainers; Chesapeake Energy and FTS International among losers\" data-tweet=\"$PED $FOE $FTK - PEDEVCO and Ferro among Energy/Materials gainers; Chesapeake Energy and FTS International among losers https://seekingalpha.com/news/3518172-pedevco-and-ferro-among-energy-materials-gainers-chesapeake-energy-and-fts-international?source=tweet\" data-url=\"https://seekingalpha.com/news/3518172-pedevco-and-ferro-among-energy-materials-gainers-chesapeake-energy-and-fts-international\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518166\" data-ts=\"1573584509\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SDC\" target=\"_blank\">SDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518166-all-eyes-on-smiledirectclub-ahead-of-q3-report-shares-down-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">All eyes on SmileDirectClub ahead of Q3 report; shares down 4%</a></h4><ul><li>IPO flop SmileDirectClub (<a href='https://seekingalpha.com/symbol/SDC' title='SmileDirectClub, Inc.'>SDC</a> <font color=\"red\">-4.4%</font>) is set to release Q3 results after the close today, its first quarterly report since its U.S. debut on September 12. Shares are currently exchanging hands 50% below its $23 offering price due to a range of issues including the appearance of <a href=\"https://seekingalpha.com/news/3498965-smiledirectclub-flops-u-s-debut\" target=\"_blank\">self-dealing</a> by the CEO, headwinds-generating legislation in California and its lack of disclosure that some of its stores were \"<a href=\"https://seekingalpha.com/news/3506655-smiledirect-drops-short-seller-tweets-raids-updated\" target=\"_blank\">raided</a>\" by California authorities in May 2018, months before it <a href=\"https://seekingalpha.com/news/3492515-smiledirectclub-readies-ipo\" target=\"_blank\">filed </a>(August) a preliminary prospectus for its IPO.</li><li>Investors will be keen to hear management's update on regulatory issues and legislation that could affect its business model.</li><li>Per Yahoo Finance, consensus Q3 view is a loss/share of ($0.98) on revenue of $165.4M.</li><li>Non-GAAP EBITDA was $6.2M last quarter and $4.3M in Q3 2018.</li><li>Another key metric is average selling price &#40;ASP&#41; which was $1,764 in H1, 7% below the list price of $1,895.</li></ul><div class=\"tiny-share-widget\" data-id=\"3518166\" data-linked=\"All eyes on SmileDirectClub ahead of Q3 report; shares down 4%\" data-tweet=\"$SDC - All eyes on SmileDirectClub ahead of Q3 report; shares down 4% https://seekingalpha.com/news/3518166-all-eyes-on-smiledirectclub-ahead-of-q3-report-shares-down-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3518166-all-eyes-on-smiledirectclub-ahead-of-q3-report-shares-down-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518460\" data-ts=\"1573582888\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROK\" target=\"_blank\">ROK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518460-rockwell-automation-rockets-near-two-year-high-on-strong-q3-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rockwell Automation rockets near two-year high on strong Q3, guidance</a></h4><ul><li>Rockwell Automation (<a href='https://seekingalpha.com/symbol/ROK' title='Rockwell Automation, Inc.'>ROK</a> <font color='green'>+10.5%</font>) <a href=\"https://www.marketwatch.com/story/rockwell-automations-stock-rockets-toward-best-day-in-a-decade-after-earnings-report-upbeat-outlook-2019-11-12\" target=\"_blank\">rises to a 22-month high</a> after <a href=\"https://seekingalpha.com/news/3517938-rockwell-automation-plus-5_5-percent-fq4-beat\" target=\"_blank\">easily beating Q3 earnings estimates</a> and issuing upside guidance for next year.</li><li>ROK forecasts FY 2020 EPS of $8.70-$9.10 vs. $8.59 analyst consensus estimate on Y/Y revenue growth of 2%-5%, equating to $6.83B-$7.03B vs. $6.62 consensus.</li><li>The upbeat outlook comes despite uncertainty created by global trade tensions and a deceleration in industrial production, CEO Blake Moret said during today's <a href=\"https://seekingalpha.com/article/4305834-rockwell-automations-rok-ceo-blake-moret-q4-2019-results-earnings-call-transcript\" target=\"_blank\">earnings conference call</a>.</li><li>CFO Patrick Goris said ROK was able to \"neutralize\" the impact of tariffs through supply chain actions, including negotiations with vendors and targeted price increases.</li></ul><div class=\"tiny-share-widget\" data-id=\"3518460\" data-linked=\"Rockwell Automation rockets near two-year high on strong Q3, guidance\" data-tweet=\"$ROK - Rockwell Automation rockets near two-year high on strong Q3, guidance https://seekingalpha.com/news/3518460-rockwell-automation-rockets-near-two-year-high-on-strong-q3-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3518460-rockwell-automation-rockets-near-two-year-high-on-strong-q3-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518160\" data-ts=\"1573581959\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518160-lts-leads-financial-gainers-bch-and-bbar-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LTS leads financial gainers; BCH and BBAR among losers</a></h4><ul><li><b>Gainers:</b> Ladenburg Thalmann Financial Services (NYSEMKT:<a href='https://seekingalpha.com/symbol/LTS' title='Ladenburg Thalmann Financial Services Inc.'>LTS</a>) <font color=\"green\">+24%</font>. Cannae Holdings (NYSE:<a href='https://seekingalpha.com/symbol/CNNE' title='Cannae Holdings, Inc.'>CNNE</a>) <font color=\"green\">+12%</font>. Ashford (NYSEMKT:<a href='https://seekingalpha.com/symbol/AINC' title='Ashford Inc.'>AINC</a>) <font color=\"green\">+9%</font>.</li><li><b>Losers:</b> Kingstone Companies (NASDAQ:<a href='https://seekingalpha.com/symbol/KINS' title='Kingstone Companies, Inc.'>KINS</a>) <font color=\"red\">-9%</font>. Banco de Chile (NYSE:<a href='https://seekingalpha.com/symbol/BCH' title='Banco de Chile'>BCH</a>) <font color=\"red\">-8%</font>. Banco BBVA Argentina (NYSE:<a href='https://seekingalpha.com/symbol/BBAR' title='Banco BBVA Argentina S.A.'>BBAR</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3518160\" data-linked=\"LTS leads financial gainers; BCH and BBAR among losers\" data-tweet=\"$LTS $CNNE $AINC - LTS leads financial gainers; BCH and BBAR among losers https://seekingalpha.com/news/3518160-lts-leads-financial-gainers-bch-and-bbar-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3518160-lts-leads-financial-gainers-bch-and-bbar-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518158\" data-ts=\"1573581689\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518158-rockwell-automation-among-industrial-gainers-embraer-and-mict-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rockwell Automation among industrial gainers; Embraer and MICT among losers</a></h4><ul><li><b>Gainers: </b>U.S. Well Services (NASDAQ:<a href='https://seekingalpha.com/symbol/USWS' title='U.S. Well Services, Inc.'>USWS</a>) <font color=\"green\">+20%</font>. Rockwell Automation (NYSE:<a href='https://seekingalpha.com/symbol/ROK' title='Rockwell Automation, Inc.'>ROK</a>) <font color=\"green\">+11%</font>. Titan International (NYSE:<a href='https://seekingalpha.com/symbol/TWI' title='Titan International, Inc.'>TWI</a>) <font color=\"green\">+11%</font>. Ideal Power (NASDAQ:<a href='https://seekingalpha.com/symbol/IPWR' title='Ideal Power Inc.'>IPWR</a>) <font color=\"green\">+8%</font>.</li><li><b>Losers: </b>MICT (NASDAQ:<a href='https://seekingalpha.com/symbol/MICT' title='MICT, Inc.'>MICT</a>) <font color=\"red\">-10%</font>. NF Energy Saving (NASDAQ:<a href='https://seekingalpha.com/symbol/BIMI' title='NF Energy Saving Corporation'>BIMI</a>) <font color=\"red\">-8%</font>. Limbach Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/LMB' title='Limbach Holdings, Inc.'>LMB</a>) <font color=\"red\">-6%</font>. Embraer (NYSE:<a href='https://seekingalpha.com/symbol/ERJ' title='Embraer S.A.'>ERJ</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3518158\" data-linked=\"Rockwell Automation among industrial gainers; Embraer and MICT among losers\" data-tweet=\"$USWS $ROK $TWI - Rockwell Automation among industrial gainers; Embraer and MICT among losers https://seekingalpha.com/news/3518158-rockwell-automation-among-industrial-gainers-embraer-and-mict-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3518158-rockwell-automation-among-industrial-gainers-embraer-and-mict-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518156\" data-ts=\"1573581613\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAM\" target=\"_blank\">SAM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518156-boston-beer-perky-after-b-swallows-up-craft-brew-alliance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boston Beer perky after A-B swallows up Craft Brew Alliance</a></h4><ul> <li>Boston Beer (NYSE:<a href='https://seekingalpha.com/symbol/SAM' title='The Boston Beer Company, Inc.'>SAM</a>) is <font color=\"green\">up 1.85%</font> with some M&amp;A activity in the beer sector.</li> <li>Anheuser-Busch's acquisition of Craft Brew Alliance was made after the beer giant passed on the deal just a few months ago at a higher share price. Earlier this year, Boston Beer made a similar-sized acquisition when it snapped up Dogfish Head Brewery for $300M.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3518080-crafty-move-anheuser-busch\" target=\"_blank\">Crafty move by Anheuser-Busch</a> (Nov. 12)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3518156\" data-linked=\"Boston Beer perky after A-B swallows up Craft Brew Alliance\" data-tweet=\"$SAM - Boston Beer perky after A-B swallows up Craft Brew Alliance https://seekingalpha.com/news/3518156-boston-beer-perky-after-b-swallows-up-craft-brew-alliance?source=tweet\" data-url=\"https://seekingalpha.com/news/3518156-boston-beer-perky-after-b-swallows-up-craft-brew-alliance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518155\" data-ts=\"1573581605\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CCC\" target=\"_blank\">CCC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518155-clarivate-analytics-shares-halted-pending-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Clarivate Analytics shares halted pending news</a></h4><ul><li>The NYSE has suspended trading in Clarivate Analytics (<a href='https://seekingalpha.com/symbol/CCC' title='Clarivate Analytics Plc'>CCC</a> <font color=\"green\">+0.5%</font>) pending the release of news.</li><li><strong>Update</strong>: At its Investor Day, it provided pro forma guidance reflecting the divestment of the MarkMonitor business.</li><li><strong>Fiscal 2019</strong>: Non-GAAP revenues: $907M - 940M; non-GAAP EBITDA: $290M - 310M.</li><li><strong>Fiscal 2020</strong>: Non-GAAP revenues: $950M - 970M; non-GAAP EBITDA: $330M - 350M.</li><li><strong>Update</strong>: Shares down <font color=\"red\">1%</font> on resumption of trade.</li></ul><div class=\"tiny-share-widget\" data-id=\"3518155\" data-linked=\"Clarivate Analytics shares halted pending news\" data-tweet=\"$CCC - Clarivate Analytics shares halted pending news https://seekingalpha.com/news/3518155-clarivate-analytics-shares-halted-pending-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3518155-clarivate-analytics-shares-halted-pending-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518152\" data-ts=\"1573580388\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHK\" target=\"_blank\">CHK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518152-chesapeake-energy-plunges-to-25-year-lows\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chesapeake Energy plunges to 25-year lows</a></h4><ul><li>Chesapeake Energy (<a href='https://seekingalpha.com/symbol/CHK' title='Chesapeake Energy Corporation'>CHK</a> <font color='red'>-16.6%</font>) shares <a href=\"https://www.marketwatch.com/story/chesapeake-stock-falls-to-lowest-price-in-25-years-as-going-concern-warning-weighs-2019-11-12\" target=\"_blank\">continue their free-fall</a>, and have now shed more than half their value since the company issued a going concern warning and missed Q3 earnings expectations <a href=\"https://seekingalpha.com/news/3514479-chesapeake-issues-going-concern-warning-alongside-q3-loss\" target=\"_blank\">a week ago</a>.</li><li>CHK 8% coupon bonds due in 2027 - the company's most actively-traded bonds by volume - reportedly are fetching a record low average of 55.29 cents on the dollar.</li><li>But CHK \"has plenty of options at its disposal and a bankruptcy is not imminent in our view,\" says James Mick, a portfolio manager with Tortoise Advisors.</li><li>Mizuho analyst Paul Sankey says \"'too big to fail' remains the prevailing view on Chesapeake.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3518152\" data-linked=\"Chesapeake Energy plunges to 25-year lows\" data-tweet=\"$CHK - Chesapeake Energy plunges to 25-year lows https://seekingalpha.com/news/3518152-chesapeake-energy-plunges-to-25-year-lows?source=tweet\" data-url=\"https://seekingalpha.com/news/3518152-chesapeake-energy-plunges-to-25-year-lows\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>202&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518151\" data-ts=\"1573580047\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PFE\" target=\"_blank\">PFE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518151-upjohn-mylan-to-be-named-viatris\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Upjohn/Mylan to be named Viatris</a></h4><ul><li>The planned combination of Pfizer's (<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a> <font color=\"green\">+0.2%</font>) Upjohn unit and Mylan N.V. (<a href='https://seekingalpha.com/symbol/MYL' title='Mylan N.V.'>MYL</a> <font color=\"green\">+2.8%</font>) will be named Viatris, the companies <a href=\"https://seekingalpha.com/pr/17696344-mylan-pfizer-announce-viatris-new-company-name-planned-mylan-upjohn-combination\" target=\"_blank\">announce</a>.</li><li>Shareholders will vote on the tie-up, <a href=\"https://seekingalpha.com/news/3482634-official-mylan-pfizers-upjohn-combine\" target=\"_blank\">communicated </a>in July, in the coming months.</li><li>Pfizer stockholders will own 57% of Viatris while Mylan stockholders will own 43%. On a pro forma basis, 2020 revenues should be $19B - 20B.</li></ul><div class=\"tiny-share-widget\" data-id=\"3518151\" data-linked=\"Upjohn/Mylan to be named Viatris\" data-tweet=\"$PFE $MYL - Upjohn/Mylan to be named Viatris https://seekingalpha.com/news/3518151-upjohn-mylan-to-be-named-viatris?source=tweet\" data-url=\"https://seekingalpha.com/news/3518151-upjohn-mylan-to-be-named-viatris\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>42&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518144\" data-ts=\"1573579323\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518144-facebook-launches-pay-service-sharesplus-2_4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Facebook launches Pay service; shares +2.4%</a></h4><ul><li>Facebook (NASDAQ:<a href='https://seekingalpha.com/symbol/FB' title='Facebook, Inc.'>FB</a>) <a href=\"https://www.streetinsider.com/Corporate+News/Facebook+%28FB%29+Introduces+Facebook+Pay/16121775.html\" target=\"_blank\">says Pay</a> offers \"a convenient, secure and consistent payment\" method across its platforms, including Messenger, Instagram, and WhatsApp.</li><li>Users add their preferred payment method once and have to opt-in to each platform in order to use Pay there.</li><li>Facebook Pay will start rolling out to Facebook and Messenger this week in the United States. Use across Instagram and WhatsApp will follow at a later date.</li><li>Facebook shares are <font color=\"green\">up 2.4%</font>. Rival PayPal (NASDAQ:<a href='https://seekingalpha.com/symbol/PYPL' title='PayPal Holdings, Inc.'>PYPL</a>) is down <font color=\"red\">0.6%</font> and Square (NYSE:<a href='https://seekingalpha.com/symbol/SQ' title='Square, Inc.'>SQ</a>)<font color=\"red\"> drops 1.6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3518144\" data-linked=\"Facebook launches Pay service; shares +2.4%\" data-tweet=\"$FB $PYPL $SQ - Facebook launches Pay service; shares +2.4% https://seekingalpha.com/news/3518144-facebook-launches-pay-service-sharesplus-2_4?source=tweet\" data-url=\"https://seekingalpha.com/news/3518144-facebook-launches-pay-service-sharesplus-2_4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>98&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518141\" data-ts=\"1573578698\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABBV\" target=\"_blank\">ABBV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518141-abbvies-rinvoq-shows-positive-action-in-ankylosing-spondylitis-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AbbVie&#39;s Rinvoq shows positive action in ankylosing spondylitis study</a></h4><ul><li>A Phase 2/3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03178487?cond=Ankylosing+Spondylitis&amp;intr=Upadacitinib&amp;lead=abbvie&amp;phase=12&amp;draw=2&amp;rank=1\" target=\"_blank\">SELECT-AXIS 1</a>, evaluating AbbVie's (<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a> <font color=\"green\">+3%</font>) JAK inhibitor Rinvoq (upadacitinib) in adult patients with ankylosing spondylitis &#40;AS&#41; (a type of arthritis primarily affecting the spine) showed a <a href=\"https://seekingalpha.com/pr/17696256-new-positive-data-rinvoq-upadacitinib-signs-symptoms-patients-ankylosing-spondylitis\" target=\"_blank\">treatment benefit</a>. The results were presented at the American College of Rheumatology Annual Meeting in Atlanta.</li><li>The study met the primary endpoint of demonstrating a statistically significantly greater proportion of treated patients achieving ASAS40 (40% improvement in AS) at week 14 compared to placebo (52% vs. 26%; p&lt;0.001).</li><li>Participants were naïve to biologic disease-modifying antirheumatic drugs and had failed to respond adequately to or were intolerant of nonsteroidal anti-inflammatory drugs (NSAIDs).</li><li>The FDA approved Rinvoq in August for rheumatoid arthritis. Late-stage studies in psoriatic arthritis, Crohn's disease, atopic dermatitis, ulcerative colitis and giant cell arteritis are in process.</li></ul><div class=\"tiny-share-widget\" data-id=\"3518141\" data-linked=\"AbbVie&#39;s Rinvoq shows positive action in ankylosing spondylitis study\" data-tweet=\"$ABBV - AbbVie&#39;s Rinvoq shows positive action in ankylosing spondylitis study https://seekingalpha.com/news/3518141-abbvies-rinvoq-shows-positive-action-in-ankylosing-spondylitis-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3518141-abbvies-rinvoq-shows-positive-action-in-ankylosing-spondylitis-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518140\" data-ts=\"1573578211\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCWX\" target=\"_blank\">SCWX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518140-secureworksminus-3-on-bears-return\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SecureWorks -3% on bear&#39;s return</a></h4><ul><li>SecureWorks (NASDAQ:<a href='https://seekingalpha.com/symbol/SCWX' title='SecureWorks Corp.'>SCWX</a>) is reinstated at Sell at Goldman Sachs with a $12 price target, a 2% upside. The company has a Neutral average <a href=\"https://seekingalpha.com/symbol/SCWX/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li><li>The firm is encouraged by SCWX's strategic direction, but notes the efforts are in the early stages.</li><li>Goldman is cautious on the company's outlook, citing recent setbacks in sales productivity and competitive pressure.</li><li>SecureWorks shares are <font color=\"red\">down 3%</font> to $11.37.</li></ul><div class=\"tiny-share-widget\" data-id=\"3518140\" data-linked=\"SecureWorks -3% on bear&#39;s return\" data-tweet=\"$SCWX - SecureWorks -3% on bear&#39;s return https://seekingalpha.com/news/3518140-secureworksminus-3-on-bears-return?source=tweet\" data-url=\"https://seekingalpha.com/news/3518140-secureworksminus-3-on-bears-return\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518138\" data-ts=\"1573578029\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518138-consumer-top-5-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top 5 Gainers / Losers</a></h4><ul><li><b>Gainers: </b>Craft Brew Alliance (NASDAQ:<a href='https://seekingalpha.com/symbol/BREW' title='Craft Brew Alliance, Inc.'>BREW</a>) <font color=\"green\">+122%</font>. Verso (NYSE:<a href='https://seekingalpha.com/symbol/VRS' title='Verso Corporation'>VRS</a>) <font color=\"green\">+22%</font>. Vapotherm (NYSE:<a href='https://seekingalpha.com/symbol/VAPO' title='Vapotherm, Inc.'>VAPO</a>) <font color=\"green\">+13%</font>. Motorcar Parts of America (NASDAQ:<a href='https://seekingalpha.com/symbol/MPAA' title='Motorcar Parts of America, Inc.'>MPAA</a>) <font color=\"green\">+9%</font>. Adecoagro (NYSE:<a href='https://seekingalpha.com/symbol/AGRO' title='Adecoagro S.A.'>AGRO</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Sypris Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/SYPR' title='Sypris Solutions, Inc.'>SYPR</a>) <font color=\"red\">-20%</font>. Dogness (International) (NASDAQ:<a href='https://seekingalpha.com/symbol/DOGZ' title='Dogness &#40;International&#41; Corporation'>DOGZ</a>) <font color=\"red\">-10%</font>. Farmmi (NASDAQ:<a href='https://seekingalpha.com/symbol/FAMI' title='Farmmi, Inc.'>FAMI</a>) <font color=\"red\">-8%</font>. Edgewell Personal Care (NYSE:<a href='https://seekingalpha.com/symbol/EPC' title='Edgewell Personal Care Company'>EPC</a>) <font color=\"red\">-8%</font>. Workhorse Group (NASDAQ:<a href='https://seekingalpha.com/symbol/WKHS' title='Workhorse Group Inc.'>WKHS</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3518138\" data-linked=\"Consumer - Top 5 Gainers / Losers\" data-tweet=\"$BREW $VRS $VAPO - Consumer - Top 5 Gainers / Losers https://seekingalpha.com/news/3518138-consumer-top-5-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3518138-consumer-top-5-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518130\" data-ts=\"1573576979\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRIP\" target=\"_blank\">TRIP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518130-tripminus-1_2-on-street-low-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TRIP -1.2% on Street-low target</a></h4><ul><li>Jefferies reiterates its Underperform rating on TripAdvisor (NASDAQ:<a href='https://seekingalpha.com/symbol/TRIP' title='TripAdvisor, Inc.'>TRIP</a>) and cuts the target from $36 to $28, which matches JPMorgan's target. The company has a Neutral average <a href=\"https://seekingalpha.com/symbol/TRIP/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li><li>The firm cites TRIP's recent <a href=\"https://seekingalpha.com/news/3515871-tripadvisor-reports-downside-q3-trip-com-partnership\" target=\"_blank\">earnings report</a>, which \"notably\" diminished visibility. Jefferies isn't sure TRIP management's response will be sufficient to \"turn things around.\"</li><li>TripAdvisor is facing headwinds related to search engine optimization, which could persist into 2020 and beyond.</li><li>TRIP shares are <font color=\"red\">down 1.2%</font> to $31.36.</li></ul><div class=\"tiny-share-widget\" data-id=\"3518130\" data-linked=\"TRIP -1.2% on Street-low target\" data-tweet=\"$TRIP - TRIP -1.2% on Street-low target https://seekingalpha.com/news/3518130-tripminus-1_2-on-street-low-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3518130-tripminus-1_2-on-street-low-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518123\" data-ts=\"1573576422\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSNT\" target=\"_blank\">SSNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518123-silversun-technologies-reports-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SilverSun Technologies reports Q3 results</a></h4><ul><li>SilverSun Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/SSNT' title='SilverSun Technologies, Inc.'>SSNT</a>): Q3 GAAP EPS of $1.70.</li><li>Revenue of $10.1M (+0.4% Y/Y)</li><li>Shares <font color=\"green\">+8%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17696236-silversun-technologies-reports-third-quarter-2019-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3518123\" data-linked=\"SilverSun Technologies reports Q3 results\" data-tweet=\"$SSNT - SilverSun Technologies reports Q3 results https://seekingalpha.com/news/3518123-silversun-technologies-reports-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3518123-silversun-technologies-reports-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518121\" data-ts=\"1573576079\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518121-poultry-names-rally-on-margin-hopes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Poultry names rally on margin hopes</a></h4><ul> <li>Pilgrim's Pride (<a href='https://seekingalpha.com/symbol/PPC' title='Pilgrim&#39;s Pride Corporation'>PPC</a> <font color='green'>+2.6%</font>) and Sanderson Farms (<a href='https://seekingalpha.com/symbol/SAFM' title='Sanderson Farms, Inc.'>SAFM</a> <font color='green'>+2.7%</font>) are higher after Tyson Foods' (<a href='https://seekingalpha.com/symbol/TSN' title='Tyson Foods, Inc.'>TSN</a> <font color='green'>+5.2%</font>) FY20 outlook includes a projection for adjusted operating margin of 6% to 8% in the chicken segment before impacts from African Swine Fever are factored in. That rate is an improvement from Tyson's chicken operating margin in 2019.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3518053-tyson-breaks-higher-guidance-chewed\" target=\"_blank\">Tyson breaks higher after guidance chewed on</a> (Nov. 12)</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3518121\" data-linked=\"Poultry names rally on margin hopes\" data-tweet=\"$PPC $SAFM $TSN - Poultry names rally on margin hopes https://seekingalpha.com/news/3518121-poultry-names-rally-on-margin-hopes?source=tweet\" data-url=\"https://seekingalpha.com/news/3518121-poultry-names-rally-on-margin-hopes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518118\" data-ts=\"1573575550\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOG\" target=\"_blank\">NOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518118-northern-oil-on-rise-q3-production-jumps-53-y-y\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Northern Oil on the rise as Q3 production jumps 53% Y/Y</a></h4><ul><li>Northern Oil and Gas (<a href='https://seekingalpha.com/symbol/NOG' title='Northern Oil and Gas, Inc.'>NOG</a> <font color='green'>+3.4%</font>) gaps higher despite missing <a href=\"https://seekingalpha.com/news/3517826-northern-oil-and-gas-eps-misses-0_02-misses-revenue\" target=\"_blank\">Q3 earnings</a> estimates, as oil and gas sales rose more than 8% Y/Y to $158M despite 4,500 boe/day of shut-ins and curtailments during the quarter.</li><li>Q3 cash flow from operations, excluding a $32.5M net decrease from  changes in working capital and other items, rose 11% Q/Q to $103.5M.</li><li>Q3 production totaled 3.8M boe and averaged 40,786 boe/day, up 53% Y/Y and 17% Q/Q.</li><li>Ongoing production curtailments resulted in a 5% Q/Q increase in  lease operating expenses to $8.62/boe in the quarter.</li><li>Due to Ground Game success over the last 12 months and an acceleration  in development activity, NOG says it expects to add an additional 5-7 net  wells to production from the Ground Game, for a total of 38-41 total  net wells added to production during 2019.</li></ul><div class=\"tiny-share-widget\" data-id=\"3518118\" data-linked=\"Northern Oil on the rise as Q3 production jumps 53% Y/Y\" data-tweet=\"$NOG - Northern Oil on the rise as Q3 production jumps 53% Y/Y https://seekingalpha.com/news/3518118-northern-oil-on-rise-q3-production-jumps-53-y-y?source=tweet\" data-url=\"https://seekingalpha.com/news/3518118-northern-oil-on-rise-q3-production-jumps-53-y-y\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518115\" data-ts=\"1573575110\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518115-amarin-leads-healthcare-gainers-t2-biosystems-and-solid-biosciences-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amarin leads healthcare gainers; T2 Biosystems and Solid Biosciences among losers</a></h4><ul><li><b>Gainers: </b>Amarin (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRN' title='Amarin Corporation plc'>AMRN</a>) <font color=\"green\">+21%</font>. Acasti Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ACST' title='Acasti Pharma Inc.'>ACST</a>) <font color=\"green\">+17%</font>. Kadmon Holdings (NYSE:<a href='https://seekingalpha.com/symbol/KDMN' title='Kadmon Holdings, Inc.'>KDMN</a>) <font color=\"green\">+13%</font>. Concert Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CNCE' title='Concert Pharmaceuticals, Inc.'>CNCE</a>) <font color=\"green\">+13%</font>. Apyx Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/APYX' title='Apyx Medical Corporation'>APYX</a>) <font color=\"green\">+11%</font>.</li><li><b>Losers: </b>Solid Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/SLDB' title='Solid Biosciences Inc.'>SLDB</a>) <font color=\"red\">-69%</font>. Diplomat Pharmacy (NYSE:<a href='https://seekingalpha.com/symbol/DPLO' title='Diplomat Pharmacy, Inc.'>DPLO</a>) <font color=\"red\">-59%</font>. T2 Biosystems (NASDAQ:<a href='https://seekingalpha.com/symbol/TTOO' title='T2 Biosystems, Inc.'>TTOO</a>) <font color=\"red\">-22%</font>. Oramed Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ORMP' title='Oramed Pharmaceuticals Inc.'>ORMP</a>) <font color=\"red\">-14%</font>. InspireMD (NYSEMKT:<a href='https://seekingalpha.com/symbol/NSPR' title='InspireMD, Inc.'>NSPR</a>) <font color=\"red\">-13%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3518115\" data-linked=\"Amarin leads healthcare gainers; T2 Biosystems and Solid Biosciences among losers\" data-tweet=\"$AMRN $ACST $KDMN - Amarin leads healthcare gainers; T2 Biosystems and Solid Biosciences among losers https://seekingalpha.com/news/3518115-amarin-leads-healthcare-gainers-t2-biosystems-and-solid-biosciences-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3518115-amarin-leads-healthcare-gainers-t2-biosystems-and-solid-biosciences-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518114\" data-ts=\"1573575005\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVR\" target=\"_blank\">NVR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518114-nvrminus-1_1-after-chairman-sells-39m-of-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NVR -1.1% after chairman sells $39M of shares</a></h4><ul><li>NVR (NYSE:<a href='https://seekingalpha.com/symbol/NVR' title='NVR, Inc.'>NVR</a>) <font color=\"red\">slips 1.1%</font> after its chairman, Dwight Schar, <a href=\"https://seekingalpha.com/filing/4694940\" target=\"_blank\">sells 11,393 shares</a> in two transactions for ~$39M.</li><li>Sold 7,163 shares at $3,436.92 per share on Nov. 7 and 4,230 shares for $3,398.30 per share on Nov. 8.</li><li>Schar still owns about 40,000 shares after the transactions.</li></ul><div class=\"tiny-share-widget\" data-id=\"3518114\" data-linked=\"NVR -1.1% after chairman sells $39M of shares\" data-tweet=\"$NVR - NVR -1.1% after chairman sells $39M of shares https://seekingalpha.com/news/3518114-nvrminus-1_1-after-chairman-sells-39m-of-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3518114-nvrminus-1_1-after-chairman-sells-39m-of-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518113\" data-ts=\"1573574941\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTD\" target=\"_blank\">TTD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518113-trade-desk-names-amzn-vet-cfo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trade Desk names AMZN vet as CFO</a></h4><ul><li>The Trade Desk (<a href='https://seekingalpha.com/symbol/TTD' title='The Trade Desk, Inc.'>TTD</a> <font color='green'>+1.4%</font>) <a href=\"https://seekingalpha.com/pr/17696220-trade-desk-chief-financial-officer-paul-ross-retire-amazon-s-blake-grayson-appointed-new-cfo\" target=\"_blank\">announces</a> that CFO Paul Ross has retired.</li><li>The company appoints Blake Grayson to succeed Ross.</li><li>Grayson most recently worked at Amazon, serving as the VP of Finance for the International Consumer business.</li></ul><div class=\"tiny-share-widget\" data-id=\"3518113\" data-linked=\"Trade Desk names AMZN vet as CFO\" data-tweet=\"$TTD - Trade Desk names AMZN vet as CFO https://seekingalpha.com/news/3518113-trade-desk-names-amzn-vet-cfo?source=tweet\" data-url=\"https://seekingalpha.com/news/3518113-trade-desk-names-amzn-vet-cfo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518110\" data-ts=\"1573574408\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APDN\" target=\"_blank\">APDN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518110-applied-dna-sciences-up-181-on-use-of-technology-to-tag-leather\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Applied DNA Sciences up 181% on use of technology to tag leather</a></h4><ul><li>Thinly traded nano cap Applied DNA Sciences (<a href='https://seekingalpha.com/symbol/APDN' title='Applied DNA Sciences, Inc.'>APDN</a> <font color=\"green\">+181.4%</font>) rockets on a whopping 180x surge in volume in reaction to the <a href=\"https://seekingalpha.com/pr/17695917-successful-dna-tagging-leather-one-world-s-largest-tanneries\" target=\"_blank\">successful DNA tagging</a> of leather at a large tannery in Asia.</li><li>The work follows a research project in the UK that showed its SigNature DNA could be successfully used to <a href=\"https://adnas.com/leather/\" target=\"_blank\">trace leather</a> through the supply chain, from the farm to the store.</li></ul><div class=\"tiny-share-widget\" data-id=\"3518110\" data-linked=\"Applied DNA Sciences up 181% on use of technology to tag leather\" data-tweet=\"$APDN - Applied DNA Sciences up 181% on use of technology to tag leather https://seekingalpha.com/news/3518110-applied-dna-sciences-up-181-on-use-of-technology-to-tag-leather?source=tweet\" data-url=\"https://seekingalpha.com/news/3518110-applied-dna-sciences-up-181-on-use-of-technology-to-tag-leather\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518107\" data-ts=\"1573574235\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GFI\" target=\"_blank\">GFI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518107-gold-fields-says-south-deep-mine-revival-prompt-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gold Fields says South Deep mine revival could prompt deal</a></h4><ul><li>The turnaround at the South Deep mine <a href=\"https://www.miningweekly.com/article/gold-fields-says-south-africa-mine-turnaround-opens-way-for-deal-2019-11-12\" target=\"_blank\">opens the way</a> for Gold Fields (<a href='https://seekingalpha.com/symbol/GFI' title='Gold Fields Limited'>GFI</a> <font color='red'>-1.7%</font>) to make a deal after it returned to profit in 2019 following more than 10 years of losses, Bloomberg reports.</li><li>GFI would consider different \"corporate structures\" for South Deep, but the mine needs to build a track record of profitability before a final decision is taken in February 2021, CEO Nick Holland says.</li><li>The company <a href=\"https://seekingalpha.com/news/3517051-gold-fields-maintains-production-outlook-2019\" target=\"_blank\">on Friday</a> raised South Deep's production targets for this year  and next, and expects the operation to  produce 5%-10% more than its initial 2019 guidance of 193K oz.</li><li>But investors remain skeptical after the mine repeatedly missed goals over  the past decade, and power shortages and regulatory uncertainties in  South Africa are compounding the challenges already faced by one of the world's  deepest mines, Holland says.</li><li>\"To get people to believe it can work we have to show good performance over a long period of time,\" the CEO tells Bloomberg.</li></ul><div class=\"tiny-share-widget\" data-id=\"3518107\" data-linked=\"Gold Fields says South Deep mine revival could prompt deal\" data-tweet=\"$GFI - Gold Fields says South Deep mine revival could prompt deal https://seekingalpha.com/news/3518107-gold-fields-says-south-deep-mine-revival-prompt-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3518107-gold-fields-says-south-deep-mine-revival-prompt-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518105\" data-ts=\"1573573918\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RVVTF\" target=\"_blank\">RVVTF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518105-revive-therapeutics-inks-loi-to-acquire-cannabis-focused-software-developer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Revive Therapeutics inks LOI to acquire cannabis-focused software developer</a></h4><ul><li>Revive Therapeutics (<a href='https://seekingalpha.com/symbol/RVVTF' title='Revive Therapeutics Ltd.'>OTCQB:RVVTF</a> <font color=\"green\">+30.6%</font>) has <a href=\"https://seekingalpha.com/pr/17695500-revive-therapeutics-announces-non-binding-letter-intent-acquire-greeninsightz-limited\" target=\"_blank\">signed </a>a non-binding letter of intent &#40;LOI&#41; to acquire <a href=\"http://www.greeninsightz.com/\" target=\"_blank\">GreenInsightz Limited</a>, a developer of artificial intelligence software focused on the cannabis sector, via an amalgamation or other type of business combination.</li><li>GreenInsightz uses its patented technology to analyze social media datasets aimed at more effective targeting of cannabis users.</li></ul><div class=\"tiny-share-widget\" data-id=\"3518105\" data-linked=\"Revive Therapeutics inks LOI to acquire cannabis-focused software developer\" data-tweet=\"$RVVTF - Revive Therapeutics inks LOI to acquire cannabis-focused software developer https://seekingalpha.com/news/3518105-revive-therapeutics-inks-loi-to-acquire-cannabis-focused-software-developer?source=tweet\" data-url=\"https://seekingalpha.com/news/3518105-revive-therapeutics-inks-loi-to-acquire-cannabis-focused-software-developer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518104\" data-ts=\"1573573722\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518104-overstock-sells-off-after-new-stock-sale-agreement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Overstock sells off further after new stock sale agreement</a></h4><ul> <li>Overstock.com (<a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a> <font color=\"red\">-15%</font>) turns even lower after the company amends an at-the-market sales agreement with JonesTrading to cover up to $300M worth of stock.</li><li>Of course, double-digit swings in share price either up or down or nothing new for OSTK this year.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3517989-overstock-com-eps-misses-0_27-misses-revenue\" target=\"_blank\">Overstock.com EPS misses by $0.27, misses on revenue</a> (Nov. 12)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3518014-overstock-com-minus-3-percent-earnings-disappoint\" target=\"_blank\">Overstock.com -3% after earnings disappoint</a> (Nov. 12)</li> <li><a href=\"https://seekingalpha.com/filing/4695050\" target=\"_blank\">SEC Form 8-K</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3518104\" data-linked=\"Overstock sells off further after new stock sale agreement\" data-tweet=\"$OSTK - Overstock sells off further after new stock sale agreement https://seekingalpha.com/news/3518104-overstock-sells-off-after-new-stock-sale-agreement?source=tweet\" data-url=\"https://seekingalpha.com/news/3518104-overstock-sells-off-after-new-stock-sale-agreement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518101\" data-ts=\"1573573672\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HZN\" target=\"_blank\">HZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518101-horizon-global-stumbles-24-post-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Horizon Global stumbles 24% post Q3 results</a></h4><ul><li>Horizon Global (<a href='https://seekingalpha.com/symbol/HZN' title='Horizon Global Corporation'>HZN</a> <font color=\"red\">-24%</font>) reported Q3 revenue decrease of 8.3% Y/Y to $177.85M, due to lower net sales in Horizon Americas.</li><li>Company says they faced significant headwinds in Americas operations during Q3, with operational and execution issues negatively impacting their ability to fill orders in the aftermarket, retail and industrial channels, resulting in lost sales, while the impact of tariffs and higher manufacturing costs impacted profitability.</li><li>Sales by segments: Horizon Americas $96.2M (-16.7% Y/Y); and Horizon Europe-Africa $81.6M (+4% Y/Y)</li><li>Q3 Gross margin <font color=\"red\">declined by 190 bps</font> to 15.9%.</li><li>Q3 Operating loss reduced to $12.76M, compared to $29.9M a year ago.</li><li>Net cash used for operating activities for continuing operations YTD was $65.8M, compared to $74.54M.</li><li>Q3 Adj. EBITDA slipped to negative $3.05M, due to lower net sales and reduced gross margin in Horizon Americas; as compared to $9.81M a year ago.</li><li>Company completed the sale of APAC for $209.6M in net cash proceeds after payment of debt and transaction costs associated with operations and the transaction.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3517851-horizon-global-eps-1_47\" target=\"_blank\">Horizon Global EPS of -$1.47</a> (Nov. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3518101\" data-linked=\"Horizon Global stumbles 24% post Q3 results\" data-tweet=\"$HZN - Horizon Global stumbles 24% post Q3 results https://seekingalpha.com/news/3518101-horizon-global-stumbles-24-post-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3518101-horizon-global-stumbles-24-post-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518095\" data-ts=\"1573573124\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PANW\" target=\"_blank\">PANW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518095-bull-returns-to-panw-on-sector-trends\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bull returns to PANW on sector trends</a></h4><ul><li>Palo Alto Networks (NYSE:<a href='https://seekingalpha.com/symbol/PANW' title='Palo Alto Networks, Inc.'>PANW</a>) is reinstated at Buy at Goldman Sachs with a $295 target, a 25% upside. The company has a Bullish <a href=\"https://seekingalpha.com/symbol/PANW/ratings/sell-side-ratings\" target=\"_blank\">average Sell Side rating</a>.</li><li>The firm cites an attractive view on the IT Security sector, which has attractive exposures to growth technology.</li><li>Palo Alto is well positioned to maintain its leadership position and is focusing on technology investments.</li><li>Palo Alto shares are <font color=\"green\">up 1.2%</font> to $238.34.</li></ul><div class=\"tiny-share-widget\" data-id=\"3518095\" data-linked=\"Bull returns to PANW on sector trends\" data-tweet=\"$PANW - Bull returns to PANW on sector trends https://seekingalpha.com/news/3518095-bull-returns-to-panw-on-sector-trends?source=tweet\" data-url=\"https://seekingalpha.com/news/3518095-bull-returns-to-panw-on-sector-trends\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518094\" data-ts=\"1573573074\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARGO\" target=\"_blank\">ARGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518094-argo-group-rises-3_8-after-kbw-takes-bullish-stance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Argo Group rises 3.8% after KBW takes bullish stance</a></h4><ul><li>Argo Group International (NYSE:<a href='https://seekingalpha.com/symbol/ARGO' title='Argo Group International Holdings, Ltd.'>ARGO</a>)<font color=\"green\"> advances 3.8%</font> after Keefe, Bruyette &amp; Woods analyst Christopher Campbell upgrades the stock to outperform from market perform.</li><li>Campbell estimates Argo will take a $53M reserve charge in Q4 to deal with leftover international deficiency gap and sees this restoring \"balance sheet confidence.\"</li><li>His rating contrasts with <a href=\"https://seekingalpha.com/symbol/ARGO/ratings/quant-ratings\" target=\"_blank\">Bearish </a>quant rating; Sell-Side average rating is <a href=\"https://seekingalpha.com/symbol/ARGO/ratings/sell-side-ratings\" target=\"_blank\">Neutral </a>(1 Very Bullish, 4 Neutral).</li></ul><div class=\"tiny-share-widget\" data-id=\"3518094\" data-linked=\"Argo Group rises 3.8% after KBW takes bullish stance\" data-tweet=\"$ARGO - Argo Group rises 3.8% after KBW takes bullish stance https://seekingalpha.com/news/3518094-argo-group-rises-3_8-after-kbw-takes-bullish-stance?source=tweet\" data-url=\"https://seekingalpha.com/news/3518094-argo-group-rises-3_8-after-kbw-takes-bullish-stance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518090\" data-ts=\"1573572994\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XFOR\" target=\"_blank\">XFOR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518090-x4-pharma-up-3-on-accelerated-review-status-in-u-s-for-mavorixafor\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">X4 Pharma up 3% on accelerated review status in U.S. for mavorixafor</a></h4><ul><li>Thinly traded micro cap X4 Pharmaceuticals (<a href='https://seekingalpha.com/symbol/XFOR' title='X4 Pharmaceuticals, Inc.'>XFOR</a> <font color=\"green\">+2.5%</font>) is up, albeit on miniscule volume of 2,600 shares, in reaction to <a href=\"https://seekingalpha.com/pr/17695517-x4-pharmaceuticals-receives-breakthrough-therapy-designation-fda-mavorixafor-treatment-whim\" target=\"_blank\">Breakthrough Therapy status</a> for lead candidate mavorixafor for a rare inherited immunodeficiency disorder called <a href=\"https://rarediseases.org/rare-diseases/whim-syndrome/\" target=\"_blank\">WHIM syndrome</a>, an Orphan Drug indication in both the U.S. and Europe.</li><li>A Phase 3 study is next up.</li><li>Breakthrough Therapy status provides for more intensive guidance from the FDA on development, the involvement of more senior agency personnel and a rolling review of the marketing application.</li><li>Mavorixafor is a small molecule antagonist of a protein called chemokine receptor type 4 (CXCR4). WHIM syndrome is caused by a mutation in the single gene that encodes the protein.</li></ul><div class=\"tiny-share-widget\" data-id=\"3518090\" data-linked=\"X4 Pharma up 3% on accelerated review status in U.S. for mavorixafor\" data-tweet=\"$XFOR - X4 Pharma up 3% on accelerated review status in U.S. for mavorixafor https://seekingalpha.com/news/3518090-x4-pharma-up-3-on-accelerated-review-status-in-u-s-for-mavorixafor?source=tweet\" data-url=\"https://seekingalpha.com/news/3518090-x4-pharma-up-3-on-accelerated-review-status-in-u-s-for-mavorixafor\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518091\" data-ts=\"1573572533\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BOX\" target=\"_blank\">BOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518091-jmp-expects-rocky-q3-for-box-sharesminus-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JMP expects rocky Q3 for Box; shares -4%</a></h4><ul><li>JMP downgrades Box (NYSE:<a href='https://seekingalpha.com/symbol/BOX' title='Box, Inc.'>BOX</a>) from Market Outperform to Market Perform, expecting a \"challenging\" Q3 report on November 26.</li><li>Analyst Erik Suppiger thinks the company's pipeline has slowed and expects a downside outlook for the January quarter.</li><li>The analyst sees Box cutting costs to expand margins, which \"could be disruptive in the near term\" and creates an execution risk during a transition period.</li><li>Box shares are <font color=\"red\">down 3.9%</font> to $15.81.</li><li>The company has a Neutral <a href=\"https://seekingalpha.com/symbol/BOX/ratings/quant-ratings\" target=\"_blank\">Quant rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3518091\" data-linked=\"JMP expects rocky Q3 for Box; shares -4%\" data-tweet=\"$BOX - JMP expects rocky Q3 for Box; shares -4% https://seekingalpha.com/news/3518091-jmp-expects-rocky-q3-for-box-sharesminus-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3518091-jmp-expects-rocky-q3-for-box-sharesminus-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518086\" data-ts=\"1573572038\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVDA\" target=\"_blank\">NVDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518086-nvidia-target-lifted-earnings-7nm-launches\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nvidia target lifted before earnings, 7nm launches</a></h4><ul><li>Susquehanna lifts its Nvidia (NASDAQ:<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a>) target from $190 to $240 ahead of the November 14 earnings report.</li><li>The firm says Nvidia \"faces the most reasonable Street expectations in quite some time,\" with potential tailwinds from improving data center, Switch, and high GPU attach rates.</li><li>Susquehanna is \"reasonably constructive\" on NVDA's near-term, but is most excited the upcoming 7nm launches.</li><li>The firm maintains a positive view on NVDA. The company has a Bullish average <a href=\"https://seekingalpha.com/symbol/NVDA/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li><li>Nvidia shares are <font color=\"green\">up 1% </font>to $210.20.</li></ul><div class=\"tiny-share-widget\" data-id=\"3518086\" data-linked=\"Nvidia target lifted before earnings, 7nm launches\" data-tweet=\"$NVDA - Nvidia target lifted before earnings, 7nm launches https://seekingalpha.com/news/3518086-nvidia-target-lifted-earnings-7nm-launches?source=tweet\" data-url=\"https://seekingalpha.com/news/3518086-nvidia-target-lifted-earnings-7nm-launches\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>39&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518084\" data-ts=\"1573571756\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SOHO\" target=\"_blank\">SOHO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518084-sotherly-hotelsplus-2_3-after-q3-beat-and-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sotherly Hotels +2.3% after Q3 beat and raise</a></h4><ul><li>Sotherly Hotels (NASDAQ:<a href='https://seekingalpha.com/symbol/SOHO' title='Sotherly Hotels Inc.'>SOHO</a>)<font color=\"green\"> rises 2.3%</font> after Q3 FFO per share beats estimates and 2019 FFO per share guidance is raised.</li><li>Now <a href=\"https://seekingalpha.com/pr/17694989-sotherly-hotels-inc-reports-financial-results-third-quarter-ended-september-30-2019\" target=\"_blank\">sees 2019 FFO per share</a> of 96 cents-98 cents vs. 91 cents-95 cents previously; compares with 98-cent average of two analyst estimates.</li><li>Sees Q3 RevPAR of $110.02-$110.91 vs. $109.60-$110.49 previously.</li><li>Sees Q3 total revenue of $184.3M-$185.8M vs. $184.2M-$187.1M; compares with the sole analyst estimate of $186.1M.</li><li>Q3 FFO per share of 31 cents improves from 6 cents in the year-ago quarter; compares with 13-cent average of two analyst estimates.</li><li>Q3 total revenue of $42.6M falls short of the single analyst estimate of $42.7M and increases from $41.4M a year ago.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3517849-sotherly-hotels-ffo-beats-0_18-misses-revenue\" target=\"_blank\">Sotherly Hotels FFO beats by $0.18, misses on revenue</a> (Nov. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3518084\" data-linked=\"Sotherly Hotels +2.3% after Q3 beat and raise\" data-tweet=\"$SOHO - Sotherly Hotels +2.3% after Q3 beat and raise https://seekingalpha.com/news/3518084-sotherly-hotelsplus-2_3-after-q3-beat-and-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3518084-sotherly-hotelsplus-2_3-after-q3-beat-and-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518080\" data-ts=\"1573571391\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518080-crafty-move-anheuser-busch\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crafty move by Anheuser-Busch</a></h4><ul> <li>Anheuser-Busch InBev (<a href='https://seekingalpha.com/symbol/BUD' title='Anheuser-Busch InBev SA/NV'>BUD</a> <font color='green'>+0.7%</font>) trades slightly higher after reversing course and deciding to acquire Craft Brew Alliance (<a href='https://seekingalpha.com/symbol/BREW' title='Craft Brew Alliance, Inc.'>BREW</a> <font color='green'>+121.4%</font>) in full.</li> <li>The beer company expects to pay for the deal in cash and sees a closing date of sometime in 2020.</li> <li>By appearances, Anheuser-Busch may have struck an opportunistic deal after BREW's share price sank in September and October when the beer giant let an option to buy the company expire. There's also the value of the new brands. \"Kona is a scarce asset whose value is partially obscured by declines with Widmer and Red Hook brands,\" noted MKM Partners analyst Bill Kirk a few months ago. \"We estimate that Kona alone is worth ~$350mn to equity holders, or ~80% upside to the current share price. This unrealistically implies significant negative value for Widmer and Red Hook,\" he calculated. Those numbers are unlikely to have changed much and make the upside potential intriguing.</li> <li>A-B picks up Redhook, Widmer Brothers Brewing, Kona Brewing Company, Omission Beer, Square Mile Cider Company, Appalachian Mountain Brewery, Cisco Brewers and Wynwood Brewing with the acquisition.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3518080\" data-linked=\"Crafty move by Anheuser-Busch\" data-tweet=\"$BUD $BREW - Crafty move by Anheuser-Busch https://seekingalpha.com/news/3518080-crafty-move-anheuser-busch?source=tweet\" data-url=\"https://seekingalpha.com/news/3518080-crafty-move-anheuser-busch\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3518074\" data-ts=\"1573570895\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DXC\" target=\"_blank\">DXC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3518074-analysts-praise-dxcs-strategic-sale-plan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts praise DXC&#39;s strategic sale plan</a></h4><ul><li>RBC (Outperform) lowers its DXC (NYSE:<a href='https://seekingalpha.com/symbol/DXC' title='DXC Technology Company'>DXC</a>) target from $67 to $43 after the <a href=\"https://seekingalpha.com/news/3517729-dxc-minus-1-percent-q2-misses\" target=\"_blank\">Q2 misses</a> came with a new strategic plan to streamline the organization to focus on enterprise technology.</li><li>The firm says DXC could experience \"significant upside\" if management can execute the strategy and achieve $7+ EPS in FY22.</li><li>Cowen (Outperform, $40 target) says \"we would be buyers\" after the earnings call provided comfort that the \"final cut has been made.\" The firm also sees the stock's valuation as attractive relative to its peers.</li><li>DXC shares are <font color=\"green\">up 12.4%</font> to $33. The company has a Bullish average <a href=\"https://seekingalpha.com/symbol/DXC/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3518074\" data-linked=\"Analysts praise DXC&#39;s strategic sale plan\" data-tweet=\"$DXC - Analysts praise DXC&#39;s strategic sale plan https://seekingalpha.com/news/3518074-analysts-praise-dxcs-strategic-sale-plan?source=tweet\" data-url=\"https://seekingalpha.com/news/3518074-analysts-praise-dxcs-strategic-sale-plan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}